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Astrocytes, a subtype of glial cells, have recently been shown to exhibit Ca2+ 
elevations in response to neurotransmitters. A Ca2+ elevation can propagate to adjacent 
astrocytes as a Ca2+ wave, which allows an astrocyte to communicate with its neighbors. 
Additionally, glutamate can be released from astrocytes via a Ca2+-dependent mechanism, 
thus modulating neuronal activity and synaptic transmission. 
In this dissertation, I investigated the roles of another endogenous signal, nitric oxide 
(NO), in astrocyte-neuron signaling. First I tested if NO is generated during astrocytic Ca2+ 
signaling by imaging NO in purified murine cortical astrocyte cultures. Physiological 
concentrations of a natural messenger, ATP, caused a Ca2+-dependent NO production. To 
test the roles of NO in astrocytic Ca2+ signaling, I applied NO to astrocyte cultures via 
addition of a NO donor, S-nitrosol-N-acetylpenicillamine (SNAP). NO induced an influx of 
external Ca2+, possibly through store-operated Ca2+ channels. The NO-induced Ca2+ 
signaling is cGMP-independent since 8-Br-cGMP, an agonistic analog of cGMP, did not 
induce a detectable Ca2+ change. The consequence of this NO-induced Ca2+ influx was 
assessed by simultaneously monitoring of cytosolic and internal store Ca2> using fluorescent 
Ca2+ indicators x-rhod-1 and mag-fluo-4. Blockade of NO signaling with the NO scavenger 
PTIO significantly reduced the refilling percentage of internal stores following ATP-induced 
Ca2+ release, suggesting that NO modulates internal store refilling. Furthermore, locally 
photo-release of NO to a single astrocyte led to a Ca2> elevation in the stimulated astrocyte 
and a subsequent Ca2+ wave to neighbors. Finally, I tested the role of NO in glutamate-
mediated astrocyte-neuron signaling by recording the astrocyte-evoked glutamate-dependent 
X 
neuronal slow inward current (SIC). Although NO is not required for the SIC, PTIO reduced 
SIC amplitude, suggesting that NO modulates glutamate release from astrocytes or glutamate 
receptor sensitivity of neurons. 
Taken together, these results demonstrate that NO is actively involved in astrocyte-
neuron signaling. NO has been implicated in many nervous system functions including 
synaptic plasticity and neurotoxicity, but its exact role and functioning mechanisms are still 
unclear. By investigating the roles of NO in astrocyte-neuron signaling, this study could 
provide new insights into development, modulation and pathology of the nervous system. 
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CHAPTER 1. INTRODUCTION 
The objective of this dissertation is to investigate the roles of nitric oxide (NO), an 
endogenous gaseous messenger, in astrocyte physiology and astrocyte-neuron signaling. I 
conceived the idea of investigating the roles of nitric oxide in astrocyte-neuron signaling and 
designed the experiments with close discussion with Dr. Philip Haydon. Except for the 
photolysis experiments, which I collaborated with Dr. Jai-Yoon Sul. I performed all the 
experiments independently. 
Astrocytes: the Unacknowledged Partner 
The impetus of this study is based on our recently revised understanding of the 
physiology of astrocytes and the interactions between astrocytes and neurons. 
For many years, astrocytes, a type of neuroglial cell, were considered to be only the 
supporting cells in the central nervous system. The word "Glia" comes from the Greek word 
"glue", and is descriptive of the bridge that astrocytes form between neuronal membrane and 
the border of the CNS (the blood system or the ventricular walls). The importance of 
astrocytes in neuronal function is suggested by the fact that they are the most abundant cell 
type in the mammalian brain. However, early electrophysiological studies revealed that 
astrocytes do not have action potentials as neurons do, and therefore they were considered as 
a "quiet" cell type. This oversight of the dynamic nature of astrocytes was predicted by the 
great neuroanatomist Ramon y Cajal who one hundred years ago wrote in "The neuron and 
the glial cell" (Cajal, 1899): "This is truly a prejudgment, in that the neuroglial cells in the 
same manner as the collagenous bundles of the connective tissue act in relation to the 
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muscular or granular cell. We accept this relationship as though it was a solid established 
fact that these Fibrils form a passive support to simply fill out and bind the tissue in a matrix 
that is swelled with nutritive substance. Every investigator who wishes to form a rational 
opinion concerning the activity of neuroglial cells should abandon this manner of this 
thinking which predisposes this judgment." But the dogma of astrocytes being only 
subservient to neurons was still dominant until very recently. 
Only until the development of fluorescent Ca2v indicators (Grynkiewicz et al.. 1985: 
Minta et al.. 1989), were astrocytes shown to be "internally Ca2" excitable" (Verkhratsky et 
al.. 1998). Astrocytes can respond to various neurochemical, electrical and mechanical 
stimuli by releasing Ca2v from internal Ca2+ stores or by influx of extracellular Ca2^: and 
Ca2* elevation in one astrocyte can spread as a Ca2~ wave to neighboring astrocytes (Cornell-
Bell et al.. 1990: Charles et al.. 1991: Cornell-Bell and Finkbeiner, 1991: Dani et al.. 1992: 
Finkbeiner. 1992; Salter and Hicks, 1994; Duffy and Mac Vicar, 1995: Porter and McCarthy, 
1996: Newman and Zahs, 1997; Bezzi et al., 1998: Harris-White et al., 1998: Guthrie et al., 
1999: Shelton and McCarthy, 2000). Additionally, Ca2+ elevation is necessary and sufficient 
for the release of glutamate, the most common excitatory neurotransmitter, from astrocytes 
(Parpura et al., 1994; Innocenti et al.. 2000). This astrocyte-released glutamate can then lead 
to a delayed Ca2^ elevation in neurons (Charles, 1994: Nedergaard. 1994; Parpura et al.. 1994; 
Hassinger et al., 1995; Pasti et al., 1997; Araque et al., 1998a; Bezzi et al., 1998), and 
modulates neuronal activity (Araque et al., 1998a; Newman and Zahs, 1998: Araque et al., 
1999; Parpura and Haydon, 2000) and synaptic transmission (Araque et al., 1998b; Kang et 
al., 1998). 
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These exciting findings challenged the old view of astrocytes as being quiet and 
submissive; instead, the roles of astrocytes as the active partner in a "tripartite synapse" 
gained more and more appreciation (Araque et al., 1999). However, the mechanisms and 
physiological and pathological consequences of astrocyte-neuron signaling are far from being 
understood. The work presented here described new findings that show that nitric oxide (NO) 
is an endogenous modulator of astrocyte-neuron signaling. 
Nitric Oxide: an Unconventional Neurotransmitter 
NO is a short-lived, endogenously produced gas which acts as a signaling molecule in 
the body. NO was first discovered as a physiological messenger in vascular smooth muscle 
relaxation (Furchgott and Zawadzki. 1980; Furchgott et al.. 1987; Ignarro et al.. 1987; Palmer 
et al., 1987; Palmer et al., 1988). The concept of a freely-diffusible gaseous molecule being 
an endogenous messenger was a breakthrough in the research of signal transduction. The 
pioneering work by Furgott. Ignarro and Murad lead to their award of the 1998 Nobel Prize 
in physiology and medicine. NO was proposed to be the "endothelium-derived relaxing 
factor (EDRF)" by Furchgott and Ignarro in 1986. and a variety of biological and 
pharmacological studies confirmed the role of NO in the cardiovascular system. 
Further studies have shown that NO also carries out diverse tasks in various other 
tissues and organs and affects almost all cellular processes. NO has especially profound 
roles in the central nervous system. Unlike most neurotransmitters that are packaged in 
synaptic vesicles and released from specialized nerve endings, NO acts as an unconventional 
neurotransmitter in that it is membrane permeant and diffuses from its site of production in 
the absence of any specialized release machinery. Hence NO can signal across greater 
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distances than the synaptic cleft and in doing so can act as a signal molecule between distant 
synapses and cells. NO signaling has now been implicated in neuronal development, 
synaptic transmission, and synaptic plasticity, as well as both neuroprotection and 
neurotoxicity (Lipton et al., 1994; Schuman and Madison. 1994; Jaffrey and Snyder. 1995; 
Ho'ischer. 1997; Crepel. 1998; Hawkins et al.. 1998). 
Endogenous NO is produced by NO synthases (NOS). There are three isoforms of 
NOSs, which are named after the tissues in which they were first cloned and characterized: 
neuronal NOS (nNOS or type 1 NOS), immune or inducible NOS (iNOS or type 2 NOS), and 
endothelial NOS (eNOS or type 3 NOS) (Bredt and Snyder, 1990; Dawson et al.. 1991; 
Lamas et al.. 1992: Sessa et al., 1992: Xie et al., 1992). Generally, nNOS and eNOS are 
constitutively expressed whereas expression of iNOS is induced during the immune response. 
All three isoforms of NOS contain a calmodulin-binding site and calmodulin binding can 
activate the enzyme. But iNOS binds calmodulin with very high affinity so that calmodulin 
forms a constitutively active subunit of iNOS. Therefore, nNOS and eNOS but not iNOS are 
activated in a dose-dependent manner by Ca2* and calmodulin. All three isoforms of NOS 
have been shown to be expressed in other tissues. For example, all three isoforms have been 
found in astrocytes (Galea et al., 1992; Bo et al., 1994; Endoh et al., 1994; Galea et al., 1994; 
Arbones et al.. 1996; Kugler and Drenckhahn, 1996: Togashi et al., 1997; Colasanti et al., 
1998: Loihl et al.. 1999: Wiencken and Casagrande, 1999). 
Nitric Oxide in Astrocytes 
Although many studies on NO in the nervous system have been conducted, there are 
very few about the roles of astrocyte-derived NO and effects of NO in astrocyte-neuron 
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signaling. Mv hypothesis is that NO is actively involved in astrocvte-neuron signaling. 
The rationale behind this hypothesis is: All three isoforms of NOS have been found in 
astrocytes in vitro and in vivo. Because the activity of nNOS and eNOS is Ca2^ -dependent, 
the stimulation-induced Ca2" elevation in astrocytes will likely cause NO to be produced. 
Once produced, NO would likely act on ryanodine receptors (Xu et al., 1998: Eu et al., 2000; 
Sun et al.. 2001). L-type Ca2> channels (Campbell et al., 1996; Poteser et al.. 2001) or store-
operated Car* channels (Favre et al., 1998; Ma et al., 1999: van Rossum et al., 2000). which 
are all known to be modulated by S-nitrosylation. NO has been demonstrated in some other 
cell types to induce Ca2* mobilization by cGMP-G Kinase-dependent activation of ADP-
ribosyl cyclase which leads to cyclic ADP ribose (cADPR)-mediated ryanodine receptors 
activation (Willmott et al., 1995: Willmott et al., 1996; Lee, 1997: Looms et al., 2001). The 
cGMP-G Kinase can also result in phosphorylation of IP3 receptors (Guihard et al., 1996: 
Rooney et al., 1996). NO has also been demonstrated to liberate Ca2" by a cGMP 
independent pathway (Volk et al., 1997; Watson et al., 1999; Berkels et al., 2000: Loitto et 
al., 2000). All these findings raise the possibility that NO may also induce Ca2+ mobilization 
in astrocytes, and in turn modulate Ca2+-dependent glutamate release from astrocyte to 
neuron. 
This dissertation examined the Ca2+-dependent formation of NO in astrocytes and the 
roles of NO in astrocytic Ca2^ signaling and astrocyte-neuron interaction. NO is a non-
conventional neurotransmitter implicated in many aspects of nervous system functions, but 
its exact role and functional mechanisms are still unclear. Astrocyte-neuron signaling is a 
relatively new but very exciting field. Astrocyte signaling and modulation of neuronal 
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activity could have critical effects on physiological and pathological processes (Araque et al.. 
2001; Mazzanti et al., 2001). 
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CHAPTER 2. BACKGROUND 
What Is an Astrocyte? 
There are four major types of glial cells, which include astrocytes, oligodendrocytes 
and microglia in the central nervous system and Schwann cells in the peripheral nervous 
system. Each type of glial cell has different histological characteristics and different 
functions. Among these, astrocytes are the primary focus of my graduate study. 
Astrocytes are of ectoderm origin, and develop from immature cells of the 
subventricular zone (Levison and Goldman. 1993: Luskin and McDermott. 1994). In 
cultures of perinatal rat optic nerve cells there are two separate types of glial precursors: a 
"type I" astrocyte precursor that generate only type 1 astrocytes and an "0-2A" progenitor 
can give rise to either oligodendrocytes or "type 2" astrocytes (Raff et al.. 1983: Raff, 1989). 
Morphologically, astrocytes can be further divided into three subgroups: radial 
astrocytes, fibrous astrocytes, and protoplasmic astrocytes with transitional forms between 
these populations. Bergmann glial cells of the cerebellum are an example of radial glial cells. 
Fibrous astrocytes have a large number of processes in all directions, whereas protoplasmic 
astrocytes, mainly located in the gray matter, have short ramified and crimped processes. 
Astrocytes are the most numerous and diverse population of glia cells. What is the 
definition of an astrocyte? In fact there is still no definite answer to this question. 
Expression of intermediate filament protein glial fibrillary acidic protein (GFAP) and S100 
have been used as specific markers of astrocytes. However, not all astrocytes express GFAP 
and the expression of GFAP can vary among astrocytes and during development and 
particularly pathological conditions (Eng and Lee, 1995). In fact Millier cells in the retina do 
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not express GFAP under normal conditions, but express GFAP under pathological conditions 
(). "Reactive astrocytes" is a term used to describe astrocytes after injury, and these cells 
exhibit a characteristic increase in GFAP level. Cultured astrocytes resemble reactive 
astrocytes in that they express increased GFAP (Eng and Lee, 1995). 
Although astrocytes are a very divergent population in term of location, shape and 
protein expression, most astrocytes share a common characteristic: they have two contact 
sites, one is the neuronal membrane (synaptic regions in the gray matter and axons in the 
white matter), and the other is the border of the CNS, either the blood system or the 
ventricular walls. This can be regarded as the definition of an astrocyte, and closely related 
to the functions of astrocytes. 
Functions of Astrocytes 
Prior to the discovery of Car* signaling in astrocytes, these cells were recognized for 
their many important functions in supporting neurons. These include: 
Mechanical support: The word "glia" came from Greek "glue". Glial cells were 
looked upon by their discoverer, Rudolph Virchow, as the "glue" (nervenkitt) that holds the 
neurons together (Virchow, 1846; Somjen, 1988). Astrocytes are the most abundant cells in 
the brain and form a mechanical scaffold for neurons. One astrocyte makes contacts with 
many neurons. 57% of synapses are surrounded by astrocyte membranes in the hippocampus 
(Ventura and Harris, 1999). 
Nutritional support: Based on the observation that astrocytes are often positioned 
between neurons and blood vessels, Golgi first speculated that astrocytes could provide 
nutritional support to neurons (Kuffler and Nicholls, 1966; Somjen, 1988). Later astrocytes 
9 
were found to be the only cells in the brain containing a substantial amount of glycogen. 
During times of glucose deprivation (such as after brain injury), glycogen can be broken 
down to provide lactate to neurons (Poitry-Yamate et al., 1995: Tsacopoulos and Magistretti. 
1996: Ransom and Fern, 1997). Thus astrocytes play a critical role by providing nutritional 
support to neurons. Astrocytes can also release various growth factors which have trophic 
effects on neurons (Labourdette and Sensenbrenner, 1995; Muller et al., 1995). 
Maintenance of extracellular K homeostasis: When neurons are excited, K* can 
accumulate in the extracellular space. Astrocytes can take up the K-" by using metabolic 
energy and a variety of voltage-gated ion channels (including a depolarization-inhibited K+ 
channel) (Orkand et al., 1966; Largo et al., 1996b). Thus astrocytes regulate extracellular IC 
concentration and maintain a stable environment for neurons and other glia cells. 
Clearance of extracellular neurotransmitters: Astrocytes processes enwrap 
central synapses where a variety of transporters clear the extracellular space of 
neurotransmitters (e.g. glutamate and G ABA) that have been released from synaptic 
terminals (Kimelberg et al., 1990; Mennerick and Zorumski. 1994: Largo et al., 1996a). The 
specialized glutamine synthetase that converts glutamate to glutamine is only present in 
astrocytes. Glutamine can then be taken up by nerve endings for resynthesizing glutamate 
and GAB A. 
Axon guidance: During CNS development, radial glia cells serve to guide axons to 
their target destinations (Rakic, 1990). Astrocytes can also inhibit, as well as stimulate, axon 
outgrowth during CNS development, and in this way provide boundaries to ensure proper 
axon targeting (Vickland and Silver, 1996). 
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Recently astrocytes have been found to play more active roles in the nervous system. 
Theses newly discovered functions include: 
Generation of new cells in adult brain: The discovery of adult stem cells in the 
brain was a breakthrough in the field of neural development (Eriksson et al.. 1998: Johansson 
et al.. 1999b: Johansson et al., 1999a). Contrary to long-held belief, new brain cells (neurons 
and glia cells) can be generated in the adult, which provided hope for repair of brain injury 
and cure of neurodegenerative diseases. Recent findings suggest that astrocytes can serve as 
stem cells (Barres, 1999: Doetsch et al., 1999). 
Synaptogenesis: The critical role of astrocytes in brain development was brought to 
our attention in 1997 when Pfriger and Barres found that astrocytes can enhance the synaptic 
efficacy of cultured retinal ganglion cells by 10 fold (Pfrieger and Barres. 1997). In 2001 the 
same group discovered that astrocytes increased the number of mature functional synapses by 
7 fold and that astrocytes are required for the maintenance of mature synapses in vitro (Ullian 
et al.. 2001). Later it was demonstrated that glia-derived cholesterol is necessary for the 
formation of mature synapses in CNS (Mauch et al.. 2001). Astrocytes can also selectively 
enhance the formation of excitatory synapse (Doyle et al., 2001) and N-type Ca:+ current in 
rat hippocampal cultures (Mazzanti and Haydon, 2001). 
Modulation of neuronal activity and neurotransmission: While astrocytes have 
long been considered only as supportive cells in the nervous system, recently they have been 
shown to directly communicate with neurons and thereby actively modulate neuronal activity 
and synaptic transmission. Because my work focuses on how NO plays a role in this aspect 
of astrocyte function, it will be the focus of the reminder of this chapter. 
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Astrocytes are "Calcium Excitable" 
Astrocytes were believed to be "quiet" cells because they do not generate action 
potentials under normal conditions. Neurons, on the other hand, can generate action 
potentials and propagate electrical excitability. But ultimately, chemical neurotransmitters 
are the signals in synapses that control information exchange. 
Astrocytes express functional neurotransmitter receptors: One of the most 
surprising developments in glial research was the discovery that glial cells (including 
astrocytes) also express functional receptors to a variety of classical neurotransmitters, 
neuromodulators and hormones previously known to affect neurons. The growing list 
includes glutamate. ATP, epinephrine, norepinephrine, GABA, acetylcholine, histamine, 
bradykinin. prostaglandins, endothelin, serotonin, substance P, oxytocin, vasopressin, 
neuropeptide Y. and complement fragments (Porter and McCarthy, 1997; Verkhratsky et al., 
1998). The expression patterns of these receptors are heterogenerous in vitro and in situ 
(Dave et al., 1991; Shao et al., 1994), and show plasticity depending on development stage 
and environment factors (Shao and McCarthy, 1993. 1994; Bernstein et al., 1996). 
Furthermore, it appears that glial cells express a set of receptors similar to those of closely 
apposed neurons (Verkhratsky and Kettenmann, 1996). These observations led to the 
following questions: why do glial cells express neurotransmitter receptors? How do glial 
cells respond to the activation of these receptors? 
Astrocytes respond to neurotransmitters with a Ca2* elevation and intercellular 
Ca2+ waves: The development of fluorescent Ca2+ indicators together with quantitative 
imaging techniques provided a great tool in answering these questions (Grynkiewicz et al., 
1985; Minta et al., 1989). Ca2+ is a ubiquitous second messenger in cells. It triggers new life 
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at fertilization, controls many developmental processes, controls diverse tasks in 
differentiated cells such as gene expression, metabolism, proliferation, contraction, secretion, 
and plasticity (Berridge et al., 2000). Because of the many pathways that it initiates. Ca2~ is 
considered to be one of the most important molecules inside a cell. A breakthrough in glial 
physiology came in 1990, when it was discovered that cultured astrocytes can respond to 
glutamate by increasing intracellular Ca2* (Cornell-Bell et al., 1990). In addition to a 
response to a neuronal glutamate signal, it was shown that astrocytes also communicate with 
each other. The rise in Ca2* levels in one astrocyte can trigger similar Ca"* increases in 
neighboring astrocytes, and cause a propagating wave of rising Ca2* levels in a network of 
astrocytes (Cornell-Bell et al.. 1990; Cornell-Bell and Finkbeiner. 1991). Later it was found 
that in addition to glutamate, a variety of other chemical, mechanical and electrical stimuli 
can also induce Ca2-1" elevations and Ca2* waves in astrocytes (Charles et al.. 1991; 
Finkbeiner, 1992; Salter and Hicks, 1994; Duffy and MacVicar, 1995; Bezzi et al., 1998; 
Guthrie et al., 1999; Shelton and McCarthy, 2000). The astrocytic Ca2* elevation and Ca2* 
wave is not an artifact of culture systems, because several studies using brain slices and slice 
cultures have now confirmed that this Ca2* signaling pathway is present in astrocytes in situ 
(Dani et al.. 1992; Duffy and MacVicar, 1995; Porter and McCarthy, 1996; Bezzi et al., 1998; 
Harris-White et al., 1998; Sul and Haydon, 2001). Ca2* waves have also been observed in 
the intact retina (Newman and Zahs, 1997). 
Sources of Ca * elevation: The source of Ca2* for elevations in cytosolic Ca2* can 
either be extracellular Ca2* or Ca2* released from internal stores. Neurotransmitters (e.g. 
glutamate, ATP)-induced Ca2* signaling in astrocytes mostly utilizes inositol (1, 4, 5)-
trisphosphate (IP^-sensitive internal stores (Cornell-Bell et al., 1990; Charles et al., 1993; 
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Salter and Hicks, 1995; Venance et al., 1997). Metabotropic receptors are coupled through 
Gq-proteins which in turn couple with phospholipase C to generate IP3. EP3 activates IP3 
receptors located on the membrane of endoplasmic reticulum (ER) and induces the release of 
Ca2*. Another type of internal store is the ryanodine-sensitive store whose natural modulator 
is cyclic-ADP ribose (cADPR). Although there were reports supporting the existence of 
ryanodine-sensitive stores in astrocytes (Langley and Pearce, 1994; Golovina and Blaustein, 
1997; Simpson et al.. 1998), their existence and participance in astrocytic Ca2* signaling are 
still controversial (Charles et al., 1993; Duffy and MacVicar. 1994). After release of Ca2* 
from the internal store, the internal store has to be replenished. Store-operated Ca2"" channels 
(SOCs) mediate Ca2* entry following agonist-induced internal store depletion, a process 
called "capacitative Ca2* entry (CCE)" (Putney, 1977). CCE is suggested to be mediated by 
a family of transient receptor potential (TRP) channel gene products (Harteneck et al., 2000; 
Clapham et al.. 2001) which were first cloned in Drosophila (Bimbaumer et al., 1996; Zhu et 
al., 1996). Electrophysiological^. the flow of Ca2* through SOCs is defined as a Ca2*-
release-activated current (I«ac) and has been well characterized in some cell types like mast 
cells (Lewis and Cahalan. 1989; Hoth and Penner, 1993), although very few studies on 
SOCs in astrocytes exist (Wu et al., 1999; Jung et al., 2000; Pizzo et al., 2001; Lo et al., 
2002). Astrocytes also express L-type voltage-gated Ca2* channels (MacVicar and Tse, 1988; 
Eriksson et al.. 1993) and Ca2*-permeant AMPA receptors (Condorelli et al., 1993; Fan et al., 
1999; lino et al., 2001; Seifert and Steinhauser, 2001) which mediate an influx of 
extracellular Ca2*. Although an astrocyte can respond to a variety of stimuli with an 
elevation of cytosolic Ca2*, Ca2* signaling exhibits the flexibility to ensure the stimulus-
specific response. 
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Mechanisms for Ca2* wave propagation: A Ca:* elevation in one astrocyte can 
spread as an intercellular Ca2* wave into neighboring astrocytes, both in vitro and in situ. 
which provides a means of information transfer between astrocytes. Both gap junctions and 
ATP are very important in the propagation of Ca2* waves. The mechanism for propagation 
of Ca2* waves was first thought to be IP3 traveling through gap-junctions, because astrocytes 
are tightly coupled with each other by gap junctions and some non-specific gap junction 
blockers could inhibit Ca2* waves (Finkbeiner, 1992: Sneyd et al.. 1994; Sneyd et al.. 1995: 
Giaume and McCarthy, 1996: Venance et al., 1997; Leybaert et al.. 1998). In addition, 
uncaging IP3 can cause a smaller Ca2* wave in astrocytes (Leybaert et al.. 1998). But later it 
was found that Ca2* waves can propagate to astrocytes across cell-free areas, which indicates 
the existence of an diffusible extracellular messenger in mediating Ca2* waves (Hassinger et 
al., 1996). This extracellular messenger was confirmed to be ATP in later studies (Guthrie et 
al., 1999). Pharmacologically blocking the extracellular ATP pathway by degrading ATP or 
by inhibiting purinergic receptors either reduced or abolished intercellular Ca2* waves 
(Guthrie et al., 1999). Luciferin-luciferase chemiluminescence assays demonstrated the 
generation of ATP during Ca2* waves and suggested that release of ATP is Ca2*-independent 
(Wang et al.. 2000). ATP was also found to be critical in mediating Ca2* waves in astrocytes 
and Millier cells in the retina (Newman. 2001). Recently it was found in the hippocampal 
slice that ATP can facilitate the glutamate-evoked Ca2* waves in astrocytes (Sul and Haydon, 
2001). It appears that the propagation of the Ca2* wave is a fine-tuned process and requires 
both gap junctions and extracellular messengers. Short-range Ca2* signaling can be caused 
by IP3 diffusing to neighboring cells through gap junctions. Longer-range Ca2* signaling 
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requires the release of ATP, which causes the regenerative production of IP3 and further 
release of ATP from neighboring astrocytes (Haydon, 2001). 
Since astrocytes are capable of responding to a variety of stimuli with an increase of 
intracellular Ca2+ and are also capable of propagating Ca2+ waves to neighboring cells, the 
classical view of astrocytes being "unexcitable" should be replaced by the concept that 
astrocytes are "calcium excitable" (Verkhratsky et al., 1998). 
Ca"+ -dependent Glutamate Release from Astrocytes Can Signal Back to Neurons 
Astrocytes can respond to signals from neurons, and also communicate with other 
astrocytes, but can they also signal back to neurons? The answer is yes. 
Astrocytes can release glutamate via a Ca"-dependent pathway: In 1994. 
Parpura et al demonstrated that glutamate can be released from cultured astrocytes, leading to 
a rise in intracellular Ca2+ in adjacent neurons (Parpura et al., 1994). Ca2+ is both necessary 
and sufficient to evoke the release of glutamate from astrocytes (Parpura et al., 1994: Araque 
et al., 1998a). Astrocytic release of glutamate is SNARE protein-dependent, suggesting that 
it is mediated by exocytosis (Araque et al., 2000; Pasti et al., 2001). Astrocytes express a set 
of proteins normally associated with vesicle release and synaptic transmission: blocking the 
function of these proteins by injection of clostridial toxins into astrocytes (Araque et al., 2000; 
Pasti et al., 2001) or by selective expression of the synaptobrevin II SNARE domain in 
astrocytes (Zhang et al., 2001) can block the Ca2+-dependent glutamate release. The release 
of glutamate during Ca2^ waves has been visualized in cortical astrocyte cultures with a 
glutamate dehydrogenase-based enzyme-linked assay (Innocenti et al., 2000). Evidence also 
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suggests that astrocytes can release glutamate in brain slices (Pasti et al.. 1997; Bezzi et al.. 
1998). 
Glutamate released from astrocytes leads to Ca2* elevations in adjacent neurons: 
Using a variety of stimuli, several groups have reported that a Ca2" elevation in astrocytes 
leads to a Ca2> elevation in adjacent neurons, both in culture (Charles. 1994; Nedergaard, 
1994; Parpura et al., 1994; Hassinger et al., 1995; Araque et al., 1998a) and in situ (Pasti et 
al.. 1997; Bezzi et al.. 1998). One group has shown that gap junction blockers can attenuate 
this astrocyte-neuron signaling (Nedergaard, 1994), but several other groups provided 
evidence that signaling is mediated by glutamate released from astrocytes acting on NMDA 
and non-NMDA receptors (Parpura et al.. 1994; Hassinger et al., 1995; Pasti et al.. 1997; 
Araque et al.. 1998a; Araque et al.. 1998b; Bezzi et al., 1998). 
Glutamate released from astrocytes can modulate neuronal electrical activity: 
Astrocytes evoke an NMDA and non-NMDA receptor-dependent slow inward current (SIC) 
in hippocampal neurons (Araque et al.. 1998a; Parpura and Haydon. 2000). In current clamp 
mode, a subthreshold depolarization elicited by injecting an outward current can become 
superthreshold by summation with the astrocyte-induced slow depolarization (Araque et al., 
1999). In the retina eyecup, changes in the light-evoked spike activity of neurons within the 
ganglion cell layer occurred when the glial Ca2+ wave reached the neuron (Newman and Zahs, 
1998). The mechanism of the modulation is suggested to be the activation of inhibitory 
interneurons which are themselves stimulated by glutamate released from glia cells. 
Glutamate released from astrocytes can modulate synaptic transmission: 
Astrocytes caused an NMDA receptor-dependent increase in the frequency of spontaneous 
miniature PSCs (Araque et al., 1998b) and a metabotropic glutamate receptor-dependent 
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inhibition of evoked PSCs in cultured hippocampal neuron (Araque et al., 1998a). In the 
hippocampal slice, repetitive firing of an intemeuron decreased the probability of synaptic 
failures in spike-evoked inhibitory postsynaptic currents (unitary IPSCs) in CA1 pyramidal 
neurons. Astrocytes were suggested to be a necessary intermediary in this activity-dependent 
modulation of inhibitory synapses because direct stimulation of astrocytes, or application of 
the GABAg-receptor agonist baclofen, potentiated miniature inhibitory postsynaptic currents 
(mlPSCs). Furthermore, the astrocyte-induced synaptic augmentation was blocked by the 
NMDA receptor antagonist D-AP5, which implies that glutamate released from astrocytes is 
responsible for the synaptic modulation (Kang et al., 1998). 
Astrocytes make intimate contacts with synapses (Ventura and Harris, 1999). The 
interactions of neurons and astrocytes are bi-directional: astrocytes can respond to 
synaptically-released chemical transmitters with a Ca2> increase: Ca2* increase in astrocytes 
evokes glutamate release from astrocytes and this astrocyte-released glutamate can then 
modulate neuronal activity and synaptic transmission. Thus astrocytes are not passive 
members of CNS, instead the classical synapse can now be viewed as a "tripartite synapse" 
including pre- and post- synaptic terminals and also the astrocyte as an active partner 
(Araque et al., 1999). 
It is worth noting that in addition to glutamate, astrocytes can also release other 
neurotransmitters and neuromodulators, which may also participate in astrocyte-neuron 
signaling. ATP acts as an excitatory neurotransmitter in addition to its function of mediating 
glial Ca2+ waves. D-serine, an endogenous modulator of NMDA receptors, can also be 
released from astrocytes (Schell et al., 1995; Wolosker et al., 1999; Mothet et al., 2000). 
Nitric oxide is also a diffusible chemical signal which can be released from astrocytes. 
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Nitric Oxide is an Endogenous Gaseous Second Messenger 
Before the discovery of nitric oxide as the endogenous "endothelium-derived relaxing 
factor (EDRF)" in 1986 (Furchgott and Zawadzki, 1980: Furchgott et al., 1987; Ignarro et al.. 
1987; Palmer et al., 1987; Palmer et al., 1988), nitric oxide was only known as a toxic gas in 
the air. The discovery that a gas, especially a potentially toxic gas, can be an endogenous 
second messenger in the body was a breakthrough in signal transduction research. The 
importance was highlighted when the 1998 Nobel Prize in physiology or medicine was 
awarded to Furchgott, Ignarro and Murad for their pioneering work on nitric oxide. Today it 
is well recognized that nitric oxide (NO) is a short-lived, endogenous 1 y produced gas which 
freely diffuses across cell membranes, acts as a signaling molecule and regulates a vast 
number of biological processes. 
Formation of Nitric Oxide: Endogenous NO is produced by Nitric Oxide Synthases 
(NOSs). They catalyze oxidation of L-arginine to NO and L-citrulline in the presence of 
NADPH and Oj, requiring FAD, FMN, heme, Ca:+, calmodulin and 6(R)-tretra-hydro-L-
biopterin (BH4) as cofactors. Three isoforms of the NOS enzyme, each the product of a 
unique gene, have been identified and characterized. They are named after the tissues in 
which they were first cloned and characterized: neuronal NOS (nNOS or type l NOS), 
immune or inducible NOS (iNOS or type 2 NOS), and endothelial NOS (eNOS or type 3 
NOS) (Bredt and Snyder, 1990; Dawson et al., 1991; Lamas et al., 1992: Sessa et al., 1992; 
Xie et al., 1992), but all three isoforms of NOSs have been shown to be expressed in other 
tissues. For example, all three isoforms have been found in astrocytes (Galea et al., 1992; Bo 
et al., 1994; Endoh et al., 1994; Galea et al., 1994; Arbones et al., 1996; Kugler and 
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Drenckhahn. 1996; Togashi et al., 1997; Colasanti et al., 1998; Loihl et al.. 1999; Wiencken 
and Casagrande, 1999) (review see (Murphy, 2000)). The human enzymes share 51-57% 
homology at the amino acid level. Generally, nNOS and eNOS are constitutively expressed 
whereas expression of iNOS is induced during the immune response. All three isoforms of 
NOSs contain a calmodulin-binding site such that calmodulin binding can activate the 
enzyme. But iNOS binds calmodulin with very high affinity so that calmodulin 
constitutively actives iNOS. Therefore, activities of nNOS and eNOS but not iNOS are Ca:+ 
and calmodulin concentration-dependent (Griffith and Stuehr, 1995; Gross and Wolin, 1995). 
A new tool to image NO formation: Only after the recent development of NO-
specific fluorescence indicators, the real-time imaging of NO production became possible. 
The DAF family of NO sensitive fluorescent indicators was first developed by Kojima and 
collaborators (Kojima et al., 1998). These compounds are based on fluorescein but with the 
addition of aromatic vicinal diamine groups, they are essentially non-fluorescent until they 
react with NO in the presence of dioxygen to form a fluorescent benzotriazoie. The diacetate 
form of DAF dyes are cell-permeant thus passively diffuses across cell membranes. Once 
inside cells, the acetate groups are cleaved by intracellular endogenous esterases. The 
fluorescence quantum yield of DAF dyes dramatically increases after reacting with NO ( 160-
fold increase for DAF-FM, from -0.005 to 0.81; figure 1). DAF-2 was the most successful 
fluorescence indicator of NO because it is highly selective to NO versus other reactive 
oxygen species and can detect NO levels as low as 5 nM. Later the same group developed 
DAF-FM (Kojima et al., 1999), a new fluorescent NO indicator, which has several 
advantages over DAF-2, such as improved sensitivity (NO detection limit: 3 nM), improved 
photostability, and pH-insensitivity. 
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Targets of Nitric Oxide Action: To understand the diversity of biological targets of 
NO, it is essential to understand that the cellular effects of NO can result from not only NO 
itself but an array of NO-related species in different redox-states such as N2O. NH2OH, NO", 
NO", NO\ N02™, N2O3-, OONO". Thus the term "NO" is used in a generic or collective 
sense. 
NO-stimulated soluble Guanylyl Cyclase(sGC)-cyclic GMP(cGMP) pathway was 
first demonstrated in the vascular system where it is of significance in controlling vessel 
dilation (Arnold et al., 1977; Rapoport et al., 1983; Bredt and Snyder, 1989). Soluble GC is 
a heme protein and because NO can interact with transition metals (Fe in this case) it can 
activate sGC and stimulate the cGMP- protein kinase G pathway. 
The NO-cGMP pathway is just a small part of the NO story. Recently with the 
development of new techniques to detect nitrosylated proteins (Jaffrey et al., 2001; Jaffrey 
and Snyder, 2001), it has been established that NO can directly nitrosylate the regulatory 
thiol group of numerous proteins, including NMDA receptors (Lipton et al.. 1993; Choi et al., 
2000; Jaffrey et al.. 2001), ryanodine receptors (Xu et al., 1998; Eu et al., 2000), L-type Ca2* 
channels (Campbell et al., 1996; Poteser et al., 2001), store-operated Ca2*" channels (Favre et 
al., 1998; Ma et al., 1999; van Rossum et al., 2000), P21™ (Lander et al., 1997), and many 
other proteins (Stamler et al., 2001). The majority of these proteins are regulated by S-
nitrosylation of a single critical cysteine residue (Lander et al.. 1997; Broillet, 2000; Choi et 
al.. 2000; Hess et al., 2001; Sun et al., 2001). S-nitrosylation is emerging as a specific and 
fundamental post-translational protein modification, potentially as important as O-
phosphoryiation (Davis et al., 2001; Lane et al., 2001; Stamler et al., 2001). 
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NO can also induce nitrosation, oxidation or nitration of proteins through its 
interaction with either O2 or O2 For example, numerous reactive nitrogen species and their 
C02~ or CI- adducts can oxidize, nitrate, or deaminate genomic DNA, resulting in strand 
breaking and mutations (Davis et al., 2001). 
Roles of Nitric Oxide: To date NO has been shown to play a role in many biological 
processes including apoptosis. inflammation, penile erection, kidney function, diabetes, 
oxidative stress and aging (Burnett et al., 1992: Bredt and Snyder, 1994: Gross and Wolin, 
1995: Nicotera et al., 1995: Lipton. 1996: Stamler and Meissner. 2001). The impetus of the 
present study is based on the finding that NO has profound roles in central nervous system. 
Under normal conditions, NO acts as a neurotransmitter. Unlike most neurotransmitters that 
are packaged in synaptic vesicles and released from specialized nerve endings, NO is an 
unconventional transmitter. NO is membrane permeant and diffuses from its site of 
production in the absence of any specialized release machinery. NO can modulate NMDA 
receptors by S-nitrosylation. Several different NO donors have been shown to either reduce 
(Manzoni et al., 1992: Omerovic et al., 1994) or enhance (Gbadegesin et al.. 1999) NMDA 
currents. NO also interacts with n-secl-syntaxin/SNAP-25 complex, thus promoting 
synaptic vesicle docking (Meffert et al., 1996). Although there are some contradictory 
results, evidence suggests that NO plays important roles in synaptic plasticity (Bohme et al., 
1993: Lipton et al., 1994: Schuman and Madison, 1994; Jaffrey and Snyder, 1995; Holscher, 
1997; Crepel, 1998; Hawkins et al., 1998). NO inhibitors blocked hippocampal long-term 
potentiation and cerebellar long-term depression, both of which are models for learning and 
memory (Crepel and Jaillard, 1990; Bohme et al., 1991; OTJell et al., 1991; Schuman and 
Madison, 1991; Bohme et al., 1993). NOS knockout and knockdown animals also showed 
deficiencies in learning and memory (O'Dell et al.. 1994: Linden et al., 1995; Kantor et al., 
1996; Son et al., 1996). NO has neuroprotective effects, but excess NO production can lead 
to neurotoxicity, which may account for neural damage in vascular stroke and AIDS 
dementia (Lipton et al., 1993; Gross and Wolin, 1995; Jaffrey and Snyder, 1995; Heales et al.. 
1997). 
Nitric Oxide in Astrocytes 
Although there have been many studies concerning NO in the nervous system, few 
have focused on the roles of NO in astrocyte-neuron signaling. All three NOS isoforms are 
expressed in astrocytes (Murphy, 2000). Astrocytes in culture were observed to form NO-
dependent cGMP in a Ca^-dependent manner in response to bradykinin, noradrenalin, 
glutamate receptor agonists (Agullo et al.. 1995; Baltrons and Garcia, 1997), or endothelin 
(Saadoun and Garcia, 1999) in cultures. NO has been measured directly in response to 
adenosine receptor acivation (Janigro et al., 1996). A recent study by Willmott et al. 
suggested that NO might induce astrocytic Ca"" signaling via cGMP-G Kinase activation of 
ryanodine receptors (Willmott et al., 2000). However, they used bolus applications of 
aqueous NO and NO donors onto a mixed culture of astrocytes and neurons, and thus were 
unable to differentiate astrocyte-derived NO from neuron-derived NO. Nor could they 
differentiate between the direct effects of NO on astrocytes and secondary effects due to NO 
effects on neurons. After partial results of our work had been presented in two conference 
meetings, another group using cerebellar slices reported that stimulation of parallel fibers on 
the cerebellar cortex triggered a transient Ca2* increase in Bergmann glial cells which could 
be blocked by NOS inhibitors and mimicked by NO donors (Matyash et al., 2001). Their 
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results suggest that Bergmann glia cells can sense neuronal-released NO and might be 
involved in NO-dependent cerebellar long-term depression. 
In summary, astrocytes are no longer considered as only the quiet supportive cells in 
the CNS; they are Ca2* excitable, and Ca2* dependent-glutamate release from astrocytes can 
modulate neuronal activity and synaptic transmission, which could have critical effects on 
physiological processes such as learning and memory, and also pathological processes such 
as epilepsy and stroke. In addition to Ca2* and glutamate, nitric oxide, a diffusible 
neurotransmitter which is implicated in many aspects of nervous system activities such as 
synaptic plasticity and neurotoxicity, might also be an important signal in astrocyte-neuron 
signaling, but its roles are largely undefined. Investigating the roles of nitric oxide in 
astrocyte-neuron signaling could provide significant new insights into development, 
modulation and pathology of the nervous system. 
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Figure I. DAF-FM is a fluorescent indicator of nitric oxide. The diagram summarizes 
the mechanism of DAF-FM as a fluorescent indicator of nitric oxide. Cells are first loaded 
with non-fluorescent DAF-FM Diacetate. This diacetate form is cell membrane permeant. 
Once DAF-FM DA enters the cell, endogenous esterases then cleave the diacetate group, 
leaving weakly-fluorescent DAF-FM. When DAF-FM reacts with nitric oxide in the 
presence of oxygen, the newly formed benzotriazole derivative of DAF-FM (DAF-FM T) is 
highly fluorescent with a excitation/emission maxima of 495/515nm. The formation of 
DAF-FM T is essentially irreversible. 
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CHAPTER 3. MATERIALS AND METHODS 
Purified Cortical Astrocyte Cultures 
The majority of the studies were performed using purified cortical astrocyte cultures. 
Post-natal 0-2 day old mice were anesthetized with halothane (Halocarbon Laboratories. 
River Edge. NJ). After the brain was removed and placed into Ca27Mg2+-free Earle's 
balanced salt solution (EBSS, pH 7.35; Gibco, Carlsbad, CA ), cortices were dissected and 
incubated for 1 hr at 37 °C in EBSS containing papain (20 U/ml), HEPES (10 mM). L-
cysteine (0.2 mg/ml), glucose (20 mM), penicillin (100 U/ml) and streptomycin (100 (ig/ml). 
Tissue was washed once with fresh EBSS and then placed in EBSS containing HEPES ( 10 
mM) and trypsin inhibitor ( 10 mg/ml) for 5 minutes to stop further digestion. After being 
rinsed, cortices were mechanically dissociated in culture medium by triturating through 
sterile serological glass pipettes. Culture medium consisted of minimum essential medium 
(Earle's salts, phenol-free;Gibco) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS; Hyclone, Logan, UT) and containing glucose (40 mM), NaHCOs (14 mM), L-
glutamine (2 mM), pyruvate (1 mM), penicillin (100 U/ml) and streptomycin (100 pg/ml), 
pH 7.35. Cells were plated into 25 cm Falcon culture flasks (BD Biosciences, Bedford, MA) 
and grown to confluence at 37°C in a humidified 5% COi/95% air atmosphere. Cells were 
fed every 3-4 days by exchanging 50% of the medium with fresh medium. After 7-14 days 
the flasks were shaken twice on a horizontal orbital shaker at 260 rpm, first for 1.5 hr, and 
then, after replacement with cold medium, again for 18 hr. The remaining adherent cells 
were enzymatically detached with trypsin (0.1%), then pelleted (800 g, 10 min), resuspended 
in culture medium, and plated onto poly-L-Lysine (1 mg/ml, MW 40,000-100,000) coated 
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glass coverslips. The cells were used in experiments after 1-4 days by which time they had 
grown to confluence. All animal procedures were approved by the Iowa State University 
LAR committee and in accordance with PHS guideline on the use of vertebrate animal in 
research. 
Primary Cultures of Mixed Hippocampal Neurons and Astrocytes 
The roles of nitric oxide on glutamate-mediated astrocyte-neuron signaling were 
studied using primary cultures of mixed hippocampal neurons and astrocytes. Post-natal 0-2 
day old mice were anesthetized with halothane. After the brain was removed and placed into 
Ca27Mg2""-free EBSS. hippocampi were dissected and incubated for I hr at 37 °C in EBSS 
containing papain (20 U/ml), HEPES (10 mM), L-cysteine (0.2 mg/ml), glucose (20 mM). 
penicillin (100 U/ml) and streptomycin (100 ng/ml). Tissue was washed once with fresh 
EBSS and then placed in EBSS containing HEPES ( 10 mM) and trypsin inhibitor ( 10 mg/ml) 
for 5 minutes to stop further digestion. After being rinsed, hippocampi were mechanically 
dissociated in culture medium by triturating through a sterile serological glass pipette. 
Culture medium consisted of Earle's minimum essential medium supplemented with 5% FBS 
and containing serum extender (mito+, 0.1%; Collaborative Biomedical Products, Bedford, 
MA), glucose (25 mM), L-glutamine (2 mM), penicillin (100 U/ml) and streptomycin (100 
gg/ml). Cells were plated onto poly-L-Lysine (1 mg/ml, MW 40,000-100,000) coated glass 
coverslips. Mitotic inhibitor (5-fluoro-2'-deoxyuridine and uridine, 5 pM) was added after 3 
days in culture. Cells were fed once a week by exchanging 30% of the medium with fresh 
medium and used after 8-18 days in culture 
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Nitric Oxide Measurement 
Relative changes in cytosolic NO concentration in astrocytes were monitored using 
the fluorescent NO probe DAF-FM. Cells were loaded with 10 fiM of DAF-FM DA 
(Molecular Probes, Eugene, OR) for 45 minutes at room temperature (20-23 °C) in normal 
external saline containing 140 mM NaCl, 5 mM KCl. 2 mM CaCh, 2 mM MgCli, 10 mM 
HEPES, 10 mM glucose, and 6 mM sucrose (pH 7.35), and then de-acetylated for 45 minutes. 
Calcium Measurement 
Ca2* levels in astrocytes were imaged by fluorescence microscopy. Unless otherwise 
specified, cultures were incubated at room temperature for 45 minutes in the presence of 
fluo-3 AM ( 10 ng/ml; Molecular Probes, Eugene, CA) and de-esterified for 45 minutes. 
Simultaneous Measurement of Cytosolic and Internal Store Ca2* 
In some experiments where we simultaneously monitored cytosolic and internal store 
Ca2* levels, purified cortical astrocyte cultures were first loaded with mag-fluo-4 AM (10 
Hg/ml: Molecular Probes) at 37 °C for 45 minutes, then washed and loaded with x-Rhod-1 
AM (2.5 ng/ml: Molecular Probes) at room temperature for 45 minutes, and then allowed to 
de-esterify for 45 minutes before imaging. 
Image Acquisition and Processing 
In single-dye imaging experiments, coverslips containing dye loaded cells were 
visualized using a cooled digital camera (ORCA; Hamamatsu, Hamamatsu City, Japan) 
attached to a Nikon 200 inverted microscope or a Noran Odyssey confocal microscope. For 
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experiments using either fluo-3 or DAF-FM, light from a xenon arc lamp (100 W) was 
filtered at 480 nm (480DF10; Omega Optical, Brattleboro, VT) and delivered to the sample 
through a 20x objective. Fluorescent emission was collected through a dichroic mirror 
(510DRLP; Omega Optical) and filtered with a 515EFLP filter (Omega Optical). Time-lapse 
images were acquired by either Automation software (Prairie Technologies. Middleton, Wl) 
or Metamorph software (Universal Imaging Corp., West Chester. PA). Frame acquisition 
interval was 3s. 
For two-wavelength imaging experiments, dye-loaded cells were excited with 488 nm 
and 568 nm laser lines, and fluorescence was imaged in two channels with a confocal 
microscope (Prairie Technologies) using Confocal-vl.47 software (Prairie Technologies). A 
488/568 nm dual dichroic mirror was used as the primary dichroic. which can reflect both 
488 nm and 568 nm excitation light. A 550DRLP dichroic mirror was used between channel 
1 and 2. Emission filters for channel 1 and 2 were 610/75BP and 525/50 BP respectively. 
All imaging experiments were performed at room temperature. We used an imaging 
chamber with a 150 p.1 volume. Normal external saline as described in Nitric Oxide 
Measurement was continuously perfused at a rate of 1-2 ml/min unless otherwise specified. 
For quantitative studies, the temporal dynamics in fluorescence were expressed as 
background-subtracted dF/Fo (%), where Fo represents the fluorescence level of the optical 
field before cell stimulation, and dF represents the change in fluorescence occurring upon 
stimulation of the cell. Statistical differences were established using the Student's t-test at 
P< 0.05 (*), P < 0.01 (**) and P <0.001 (***). Data are expressed as mean ± SEM. 
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Photolysis of Caged Nitric Oxide 
In some experiments flash photolysis was used to provide a fast localized NO 
stimulus. Caged-NO (potassium nitrosyl-pentachlororuthenate, 1 mM; Molecular Probes) 
was included in the external saline. We used a Noran Odyssey confocal upright microscope 
which contains a wide-field fluorescence illumination pathway together with an optical 
pathway for laser excitation for photolysis. A pulsed Nitrogen laser (337 nm. 3 ns pulse 
duration) launched into a UV transmitting optical fiber was used for photolysis excitation. A 
second 635 nm laser was coupled into the same optical fiber to allow the positioning of the 
UV beam. The illumination spot on the sample was approximately 6 nm in diameter. 
Stepping motors were used to move the position of the fiber in the image plane. Positioning 
and shuttering of the laser were all controlled by computer software. 
Electrophysiology 
Whole-cell patch clamp recordings were made from neurons using patch-pipettes 
made from borosilicate glass capillaries (World Precision Instruments. Sarasota, FL), with a 
DC resistance in the range of 5-10 M£2. Internal solution contained (in mM): 140 K-
gluconate, 10 EOT A. 4 Mg-ATP, 0.2 Tris-GTP, and 10 HEPES, pH 7.35. External bath 
solution contained (in mM): 140 NaCl, 5 KC1, 2 CaCl;, 2 MgCl;, 10 HEPES, 10 glucose, and 
6 sucrose, pH 7.35. The membrane potential was held at -70mV. The bath was constantly 
perfused with fresh external saline at a slow rate (~ 0.5 ml/min) throughout the recording. All 
experiments were performed at room temperature (20-23 °C). Data were sampled and 
analyzed with an Axopatch-lC amplifier and pClamp software (Axon Instruments, Union 
City, CA). Currents were filtered at 1-2 kHz and sampled above 1 kHz. The morphological 
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identification of neurons was confirmed electrophysiological^ by their ability to generate 
TTX-sensitive Na'-mediated action potentials and by the presence of fast synaptic currents. 
Confluent astrocytes, -25-150 fim from the soma of the neuron recorded from in patch clamp 
recordings, were stimulated mechanically using glass micropipettes filled with external saline. 
The incidence of astrocyte-induced slow inward currents (SICs) was defined as the 
proportion of responses relative to the total number of astrocytes on each experimental day. 
Therefore, for this variable, n values correspond to the number of experiments, whereas for 
the amplitude of the SICs, n represents the number of cells examined. Statistical differences 
were established using the Student's t-test at P< 0.05 (*), P < 0.01 (**) and P <0.001 (***). 
Data are expressed as mean + S EM. 
Immunocytochemistry 
The purity of astrocytes in the purified cortical astrocyte cultures was confirmed by 
immunocytochemistry. Co-cultures of cortical astrocytes and neurons were used as a 
positive control for neurons and astrocytes. Cultures were fixed with 4% paraformaldehyde 
in phosphate-buffered saline (PBS, pH 7.3) at room temperature for 30 minutes, and then 
rinsed with PBS and permeabilized with triton X-100 (0.25% in PBS) for 10 min. The 
cultures were then incubated in PBS containing 5% BSA, 5% normal goat serum, 0.25% 
Triton X-100 and 0.02% NaNg for 30 min to block non-specific binding. Cultures were 
incubated with mouse anti-Glial Fibrillary Acidic Protein (GFAP) monoclonal antibody 
(Sigma) and rabbit anti-Microtubule-Associated Protein 2 (MAP2) polyclonal antibody 
(Chemicon International, Temecula, CA)) for 12 hours at 4 °C. Primary antibodies were 
removed by washing with PBS containing 5% normal goat serum, 0.25% Triton X-100 and 
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0.02% NaNs. and then incubated with fluorescent dye-labeled secondary antibodies (Alexa 
Fluor® 488 goat anti-mouse IgG and Alexa Fluor® 568 goat anti-rabbit IgG; Molecular 
Probes) for 2 hours. The coverslips were then mounted in n-propyl gal I ate in glycerol onto 
glass microscope slides, and imaged with a laser scanning confocal microscope. 
Chemicals 
Caged nitric oxide, DAF-FM AM, fluo-3 AM, mag-fluo-4 AM. x-Rhod-1 AM, l.2-bis(2-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) AM and S-nitrosol-N-
acetylpenicillamine (SNAP) were purchased from Molecular Probes: 2-aminoethoxy-
diphenylborate (2-APB), NG-monomethyl-L-arginine (L-NMMA) and Nc-monomethyl-D-
arginine (D-NMMA) were from CalBiochem; all other chemicals were from Sigma unless 
otherwise specified. 
CHAPTER 4. RESULTS 
For studying the roles of nitric oxide in astrocyte-neuron signaling, it's essential to 
differentiate the astrocytic-originated nitric oxide from neuronally-derived nitric oxide and 
study the direct effect of nitric oxide on astrocytes. The purified murine cortical astrocyte 
cultures used in this study provided a good system to specifically study astrocytic nitric oxide 
production and direct effects of nitric oxide on astrocytes. After the purification procedure as 
stated in Material and Method, the cultures consisted predominately of astrocytes. 
Morphologically astrocytes can be distinguished from neurons which generally have a more 
rounded cell body, bear longer processes, and appear much brighter under a phase-contrast 
microscope. Immuno-staining with antibodies against the astrocyte specific marker glial 
fibrillary acid protein (GFAP) and the neuron specific marker microtubule-associated protein 
2 (MAP-2) confirmed that the ratio of astrocytes to neurons in the cultures were greater than 
99:1 (Figure 2). 
ATP Induces Nitric Oxide Production in Astrocytes 
ATP is a critical natural extracellular messenger involved in Ca'* signaling in 
astrocytes. It induces an astrocytic Ca2* elevation, and mediates the propagation of Ca2* 
waves between astrocytes (Guthrie et al., 1999). Activities of nNOS and eNOS are known to 
be Ca * dependent (Griffith and Stuehr, 1995: Gross and Wolin, 1995). Therefore, I tested if 
ATP can induce NO production using the new NO-sensitive fluorescence indicator DAF-FM. 
Astrocytes were loaded with DAF-FM as described in Methods. Application of 10 |iM ATP 
induced a small but reliable increase of DAF-FM fluorescence (Figure 3). Control 
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experiments confirmed that the increase of DAF-FM fluorescence was due to NO production, 
since both the NO scavenger PTIO (100 gM, 5 min) (Figure 4A) and the NOS inhibitor L-
NMMA (300 gM. 30 min). but not its inactive analog D-NMMA (300 nM. 30 min). blocked 
the ATP-induced DAF-FM fluorescence increase (Figure 3B, 45). 
In experiments using PTIO. the same cells were first stimulated with ATP. then after 
washing with normal saline for 10 minutes, perfused with PTIO for 5 minutes and stimulated 
again with ATP in the presence of PTIO. After washing for another 15 minutes, the same 
cells were stimulated a third time with ATP. The first and third ATP applications were used 
as internal controls for each cell. When NO was scavenged by PTIO. the ATP-induced 
DAF-FM fluorescence increase was significantly reduced (student's t-test. p < 0.001). The 
effect of PTIO is reversible. The average change in fluorescence intensity of DAF-FM in 
response to the three ATP applications was 3.15 ± 0.09%. 0.76 + 0.09% (ATP in PTIO), and 
2.97 ±0.07%. respectively (n = 171 cells. 4 experiments). 
When NOS activity was inhibited by L-NMMA, the average ATP-induced change in 
fluorescence of DAF-FM was significantly reduced to 0.11 ± 0.05% (n = 244; p < 0.001), 
compared to 1.99 + 0.10% (n = 188) in control conditions (Figure 4B). Parallel experiments 
demonstrated that L-NMMA had no effect on Ca2* signaling (Figure 3D). But D-NMMA, the 
inactive analog of L-NMMA did not have such effect (DAF-FM dF/Fo: 1.28 ± 0.09%; n = 
197; no significant difference from control condition), which confirmed the specificity of 
NOS inhibition by L-NMMA. 
The time course of the ATP-induced Ca2* elevation was different with that of the 
DAF-FM fluorescence increase. In response to ATP, intracellular Ca2* rose to a peak level 
within a few seconds and then gradually returned to the baseline, whereas DAF-FM 
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fluorescence increased to its peak more slowly in the presence of ATP. However, the peak of 
the first derivative of the change in DAF-FM fluorescence, i.e. the maximal rate of DAF-
FM fluorescence increase, occurred at the same time with the Ca2* peak (Figure 3O. 
suggesting that new NO is instantly (within 3 sec) generated during Ca2* signaling, and that 
the rate of NO generation is correlated with the magnitude of Ca2* elevation. This is the first 
evidence showing an endogenous Ca2* mobilizing agent in its physiological concentration is 
able to quickly induce NO production, which may have profound implications in astrocyte-
neuron signaling. 
Ca"* is Necessary for the ATP-induced NO Production 
Since the activity of NOSs are Ca2*-dependent, and ATP induces a Ca2* elevation in 
astrocytes, it is logical to test whether a Ca2* elevation is required for the ATP-induced NO 
production. In order to test this hypothesis, I chelated the cytosolic Ca2* by incubating 
astrocytes in BAPTA AM (30 |aM, 45 min). In the presence of BAPTA, ATP no longer 
induced an increase in DAF-FM fluorescence (DAF-FM dF/Fo: 0.03 ± 0.03% in BAPTA (n = 
240) vs. 2.97 + 0.08% in control (n = 174), 4 experiments each; p < 0.001; Figure AD). 
Separate experiments of imaging with the Ca2* indicator fluo-3 confirmed that BAPTA 
blocked the Ca2* increase caused by ATP (fluo-3 dF/Fo: 14.0 + 0.3% in BAPTA (n = 242) vs. 
487.8 ± 7.1% in control (n = 314), 3 experiments each; p < 0.001 ). These results 
demonstrate that an increase of internal Ca2* is necessary for the ATP-induced NO 
production. 
In addition, when astrocytes were treated with PPADS (50 |xM, 5 min), a Pz receptor 
antagonist, the ATP-induced NO production was also inhibited. The three ATP application 
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protocol was also used with the first and third ATP applications being administrated in 
normal saline whereas the second ATP application was carried out after PPADS treatment. 
The average DAF-FM dF/Fo values after the three ATP applications were: 5.83 + 0.37%, 
1.25 + 0.07% and 5.99 ± 0.40% (n = 150, 4 experiments), respectively (Figure 4Q. The 
effectiveness of PPADS in blocking astrocytic Ca2* elevation' was confirmed with Ca2* 
imaging experiments, in which PPADS reversibly blocked ATP-induced cytosolic Ca2* 
elevation in astrocytes (data not shown). This is consistent with a P: receptor-mediated Ca2* 
elevation stimulating NO production. 
Nitric Oxide Induces a Ca"* Influx into Astrocytes 
The observation that nitric oxide can be produced in astrocytes via a Ca2*-dependent 
mechanism led to a logical question: what are the roles of nitric oxide in astrocytes? Since 
Ca2* is a critical second messenger in cells, Ca2* excitability is an essential characteristic of 
astrocytes, and Ca2* waves represent the communication pathway between astrocytes, I 
determined whether nitric oxide can modulate Ca2* signaling in astrocytes. Nitric oxide has 
been shown to modulate Ca2* signaling in other cell types via a cGMP-dependent pathway or 
direct nitrosylation of proteins (Willmott et al., 1995; Gui hard et al., 1996: Rooney et al., 
1996: Willmott et al., 1996: Lee, 1997: Volk et al., 1997; Berkels et al., 2000; Loitto et al., 
2000; Looms et al., 2001), but its roles in astrocytes are largely unknown. 
In order to test the effects of NO on astrocyte Ca2* signaling, I first used NO donors, 
which are compounds which can spontaneously release NO. I applied the NO donor S-
nitrosol-N-acetylpenicillamine (SNAP) to astrocytes and asked if NO can induce a Ca2* 
elevation in astrocytes. Figure 5A shows that perfusion with 100 nM SNAP increased Ca2* 
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levels in the majority of astrocytes. The increase of Ca"* by SNAP was reversibly blocked 
by addition of the NO scavenger PTIO (100 gM; n = 114 cells. 3 experiments; p < 0.001; 
Figure 58). which confirmed this Ca2* increase is due to the action of NO, not to SNAP itself 
or other byproducts. 
While the NO donor SNAP can induce a Ca2* increase in astrocytes, the cGMP 
pathway agonist 8-Br-cGMP (up to 3 mM) did not induce any detectable change in fluo-3 
fluorescence (n = 4 experiments; data not shown), suggesting that the cGMP pathway is not 
involved in the NO-induced Ca2* signaling in astrocytes. 
Interestingly, when 100 |iM SNAP was applied to the same cells in zero-Ca2* external 
saline, it no longer induced an increase of intracellular Ca2*: however when reapplied in the 
presence of external Ca2*. SNAP could again induce cytosolic Ca"* elevations (Figure 5C 
and D), suggesting that NO stimulates a Ca2* influx pathway in astrocytes. 
Cadmium (Cd2*, a non-selective Ca2* channel blocker, 100 (J.M) and 2-aminoethoxy-
diphenylboratae (2-APB. an IP3 receptor antagonist and capacitative Ca2* entry blocker, 75 
(iM) also reversibly blocked SNAP-induced Ca2* elevations (Figure 6). Cd2* reduced the 
average fluo-3 dF/Fo by ATP to 2.9 + 0.5%. compared with 70.6 + 3.4% (first ATP 
application) and 82.7 + 2.5% (third ATP application after washing out Cd2*) of the same 
cells in the normal saline (n= 205 cells, 3 experiments)). The average fluo-3 dF/Fo induced 
by ATP in 2-APB treated cells was 2.9 + 0.5%, compared with responses of 138.7 + 5.2% 
(first ATP application) and 112.9 +4.6% (third ATP application) in normal saline and after 
washing out 2-APB (n = 96 cells, 3 experiments). In conclusion, these results show that NO 
raises astrocytic Ca2* by inducing an influx of extracellular Ca2*, and possibly by activating 
a capacitative Ca2* entry pathway (store-operated Ca2+ channels). 
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Nitric Oxide Modulates the Refilling of Internal Ca2* Stores. 
It has been shown that many neurotransmitters (ATP, glutamate, norepinephrine) 
induce an elevation of intracellular Ca2* in astrocytes by causing IPs-mediated release of Ca2* 
from internal Ca2* stores (Cornell-Bell et al., 1990: Charles et al.. 1993: Salter and Hicks. 
1995; Venance et al., 1997), but the mechanism of refilling these internal Ca2* stores is 
largely undetermined. Capacitative Ca2* entry, or store depletion-induced store refilling, has 
been intensively investigated in several other cell types (Putney. 1977: Lewis and Cahalan. 
1989: Hoth and Penner, 1993: Clapham. 1995: Zhang and McCloskey. 1995; Birnbaumer et 
al.. 1996; Parekh and Penner. 1997; Putney and McKay, 1999: van Rossum et al., 2000; 
Clapham et al., 2001), but has not been widely studied in astrocytes. Since an ATP-induced 
Ca2* elevation can induce NO production in astrocytes, and NO can induce external Ca2* 
influx, it is possible that NO production is responsible for refilling internal Ca2* stores. 
Blockade of NO signaling reduces Ca2* responses to subsequent stimulations of 
ATP: The magnitude of the increase in cytosolic Ca2* induced by ATP is correlated with the 
availability of Ca2* from internal stores. Thus if nitric oxide modulates the refilling of 
internal Ca2* stores, then blocking NO accumulation with the NO scavenger PTIO could 
reduce the Ca2* response to subsequent applications of ATP. Consequently I applied ATP 
three times to astrocytes with the first application as an internal control. Then I applied the 
NO scavenger PTIO during the second and third application of ATP to determine if blockade 
of NO signaling during ATP application led to a reduction in subsequent ATP-induced Ca2* 
response. 
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Figure 7A shows the average change in fluorescence of astrocytes in response to the 
three applications of ATP. In the first group of cells the amplitude of three Ca2" responses is 
shown in control condition as a comparison base to show that ATP is able to reliably increase 
cytosolic Ca2+ levels. In the second group, maximal depletion of internal store was promoted 
by perfusion in zero-Ca2"" external saline together with I mM EOT A during the second and 
third application of ATP. This control and zero-Ca2* EOT A group can be considered as the 
extremes of maximal and minimal refilling of internal stores against which NO treatment can 
be compared. Treatment with PTIO did not immediately affect the amplitude of ATP-
induced Ca2+ signal. However, by the third ATP stimulus, the mobilization of Ca2+ was 
modestly reduced in amplitude. This result suggests that PTIO reduced the refilling of 
internal stores following the ATP-induced Ca2+ release. The magnitude of average 
normalized Ca2" responses is presented in Figure 7B, where the increase in fluo-3 
fluorescence to the first ATP application is normalized to 100% in each cell. PTIO 
significantly reduced the response to the third ATP application from 87.3 + 0.9% in normal 
conditions to 78.3 + 0.8% (n = 3 experiments each. 176 and 259 cells for control and PTIO 
respectively; p < 0.001). Note that response of a cell to subsequent ATP application was 
always slightly smaller in magnitude, probably resulting from the desensitization of ATP 
receptors. Thus the responses in the PTIO-treated group are compared in parallel to control 
conditions. 
Simultaneous monitoring of cytosolic and internal store Ca2*: To further test for 
a role for NO signaling in regulating the Ca2+ levels of internal stores, I directly imaged 
relative Ca2+ levels of internal stores using a low-Ca2+ affinity fluorescent indicator mag-
fluo-4 (Ex/Em maxima: 493/517nm). When cells were incubated with mag-fluo-4 AM at 37 
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°C, loading of this dye into intracellular compartments was facilitated. Because the Kd.ca of 
mag-fluo-4 is 22 gM and Ca2* levels in stores are up to about 200 nM (Golovina and 
Blaustein. 2000) whereas cytosolic Ca2* concentration is about 100 nM, this indicator 
preferentially reports store Ca2* levels. After loaded with mag-fluo-4. astrocytes were then 
loaded with a high affinity Ca2~ indicator x-Rhod-1 (Ex/Em maxima: 580/602 nm: Kd. o = 
700 nM) at room temperature. Since the K& ca of this indicator is in the operating range of 
Ca2* in the cytosol, it preferentially reports cytosolic Ca2* levels. As illustrated in Figure 8A, 
using two laser lines for excitation and carefully-selected filter sets, I could spectrally 
separate the two fluorescent signals from mag-fluo-4 and x-rhod-1, and monitor in real-time 
the cytosolic and internal store Ca2* simultaneously. 
Two examples of astrocytes co-loaded with mag-fluo-4 and x-rhod-1 viewed with a 
60x objective are shown in Figure 8B. Note that x-rhod-1 staining is more homogenous, 
while mag-fluo-4 staining shows clear punctate patterns in the periphery of cells and devoid 
of fluorescence in nuclear regions (reflecting the cytoplasmic), which is consistent with x-
rhod-1 and mag-fluo-4 loading into cytosol and internal stores respectively. To test whether 
these indicators do indeed report the Ca2* levels in the two different compartments, I applied 
thapsigargin. an irreversible ER Ca2*-ATPase inhibitor. In the presence of thapsigargin, Ca2* 
leaks from ER internal stores, causing cytosolic Ca2* to increase, and causing internal stores 
to become gradually depleted. As shown in Figure 9A, thapsigargin reduced mag-fluo-4 
fluorescence, and increased x-rhod-1 fluorescence at the same time (n =4 experiments). The 
results confirm that we were simultaneously monitoring cytosolic and internal store (mostly 
ER) Ca2* with x-rhod-1 and mag-fluo-4. Although mag-fluo-4 might be loading into other 
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stores and organelles, we will refer to the mag-fluo-4 fluorescence as an indicator of internal 
Ca2* stores. 
ATP is a neurotransmitter which is known to induce Ca2* release from the ER via the 
IPs pathway. Therefore, to further confirm the validity of the two-indicator approach in 
reporting changes in cytosolic and internal store Ca2*, I applied ATP to astrocytes. In 
response to ATP, x-rhod-1 fluorescence exhibited a biphasic increase with a short latency 
peak followed by a plateau, consistent with the known biphasic cytosolic Ca2" increase to 
ATP. Simultaneous with the increase in cytosolic Ca2* was a reduction of the fluorescence of 
mag-fluo-4, in agreement with the reduction of internal store Ca2* caused by Ca2* release 
from stores (Figure 95 left). The same cells were then treated with 30 gM BAPTA AM for 
20 minutes so that cytosolic Ca2* would be chelated without affecting the release and 
refilling of store Ca2". The increase in x-rhod-1 fluorescence was blocked, but the reduction 
of mag-fluo-4 fluorescence was still the same (Figure 9B right). These results are all 
consistent with x-rhod-1 and mag-fluo-4 respectively monitoring cytosolic and internal store 
Ca2*. 
Occasionally a small transient increase in mag-fluo-4 fluorescence was observed in 
response to ATP. This small increase was abolished after cells were treated with BAPTA (n 
= 3 experiments; Figure 98), suggesting that this small increase resulted from highly-
elevated cytosolic Ca2* induced by ATP. Thus sometimes a small amount of mag-fluo-4 
might be present in cytosol, at resting Ca2* levels (-100 nM), the fluorescence from cytosolic 
mag-fluo-4 only consists a negligible fraction of total mag-fluo-4 fluorescence (remember K& 
d of mag-fluo-4 is 22 |iM), but when the cytosolic Ca2* level is highly elevated by 
stimulation (up to 1-2 nM), the total mag-fluo-4 fluorescence can be mildly contaminated 
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with cytosolic Ca'*. Since I'm mainly interested in the magnitude of store depletion and 
refilling after this transient, mag-fluo-4 can still be used as a good indicator of internal store 
Ca2*. 
Further evidence supporting the notion that these two fluorescent indicators 
preferentially report cytosolic and internal store Ca2* came from experiments in which I 
stimulated Ca2* release from internal stores by application of ATP in the presence of zero-
Ca2* EOT A external saline (Figure 9 C right graph). When ATP (20 gM) was applied to cells 
in the presence of zero-Ca2* EOT A. x-rhod-1 fluorescence increased, but this increase lacked 
an elevated plateau phase; and mag-fluo-4 fluorescence decreased in a larger magnitude than 
in Ca2*-containing saline (Figure 9C left graph). After washout of ATP, mag-fluo-4 
fluorescence did not recover until Ca2* was added back into the saline, consistent with the 
elimination of Ca2* influx and refilling of internal store by zero-Ca2* EOT A. 
Taken together, these results support the notion that the two indicators, x-rhod-1 and 
mag-fluo-4. preferentially report changes in cytosolic and internal store Ca2* respectively, 
and that they can be used for investigating the role of NO in the regulation of Ca2* store 
refilling. 
PTIO reduced the refilling percentage of internal stores: To probe the role of NO 
in store refilling, I directly visualized ATP-induced store depletion and subsequent store 
refilling and asked whether NO modulates store refilling. Figure 10 demonstrates the results 
from one such experiment using ATP. Both the images and the trace show the ATP (20 pM, 
60 sec)-induced cytosolic Ca2* elevation resulting from release of Ca2* from internal stores. 
Note that the internal stores were able to be fully refilled 2 minutes after removal of ATP 
(Figure 10S, data point d). 
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The effect of nitric oxide on the refilling of internal stores was then studied by 
blockade of NO signaling with the NO scavenger PTIO. Figure HA and 11C shows that 
when cells were pretreated with PTIO (100 gM, 10 min), internal stores were no longer able 
to fully refill, as mag-fluo-4 fluorescence did not recover to the pre-stimulation fluorescence 
intensity. If I define the refilling percentage of internal stores as the percent fluorescence 
recovery: in the presence of PTIO, Ca2* of internal stores only refilled to 71.2 ± 5.0 % after 2 
minutes after removal of ATP, as opposed to 104.5 ± 7.7% in control conditions (n = 9 
experiments: p < 0.01; Figure 115). This finding directly supports the hypothesis that nitric 
oxide modulates the refilling of internal stores. 
Nitric Oxide Induces a Ca"* Wave between Astrocytes 
Intercellular Ca2* waves provide an important mechanism for astrocytes to 
communicate with each other. Ca2* waves were first discovered in culture and later 
confirmed in situ and shown to be induced by a variety of stimuli including natural neuro-
messengers (Cornell-Bell et al., 1990; Charles et al., 1991; Cornell-Bell and Finkbeiner, 1991; 
Dani et al.. 1992: Hassinger et al.. 1996; Newman and Zahs, 1997: Harris-White et al., 1998: 
Guthrie et al., 1999: Sul and Haydon, 2001). We asked whether NO can induce a Ca2* wave 
between astrocytes by using a localized NO source. Caged nitric oxide I (potassium nitrosyl-
pentachlororuthenate) that releases nitric oxide upon UV illumination was used. Our 
photolysis instrumentation provided an effective, fast and localized NO source to directly 
stimulate a single astrocyte. The instrumentation set-up is illustrated in Figure 12A. The 
illumination spot on the sample is approximately 6 gm in diameter, which is smaller than a 
single astrocyte. 
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Photolysis (1 UV pulse, 3 ns) of caged-NO (1 mM) first induced a Ca2" elevation in 
the directly stimulated astrocyte (fluo-3 dF/Fo: 691.4 + 260.2%; n = 6; Figure 12#). The 
increase in intracellular Ca2* was not due to UV exposure, because when the same UV pulse 
was delivered to astrocytes in the absence of the caged compound, astrocytes didn't show a 
Ca2* elevation (fluo-3 dF/Fo: 1.8 ± 1.2%: n = 4; Figure 12C). In another set of control 
experiments, the NO scavenger PTIO (100 gM) prevented flash photolysis of caged NO from 
inducing a Ca2* elevation (Figure 12Q, confirming that flash photolysis normally induces a 
Ca2* signal as a result of the liberation of NO. 
Photo-release of nitric oxide not only induced a Ca2* elevation in the directly 
stimulated astrocyte, but also initiated a propagating intercellular Ca2* wave into the 
neighbors. Figure 13A shows an example of photoliberated NO-induced Ca2* waves. The 
magnitude of Ca2* rise, the rate of Ca2* rise, and the propagation rate of NO-induced Ca2* 
waves are all similar to those induced by mechanical stimulation. To determine whether the 
Ca2* increase in the neighboring cells resulted from regenerative Ca2* waves rather that due 
to diffusion of photo-released NO, we uncaged NO in a cell free area, adjacent to a cell. 
When we photo-released NO as close as 18 gm away from an astrocyte, we did not detect a 
Ca2* response in this cell (Figure 13B). Thus when we photo-released NO onto an astrocyte 
and induced a Ca2* wave which propagated for at least 50 gm (Figure 13A), this wave 
resulted from intrinsic properties of those cells rather than the diffusion of NO from the 
source of photo-release. 
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Nitric Oxide Does Not Mediate the Propagation of Ca2* Waves 
Since NO can be produced when the Ca2" level is increased, as seen by DAF-FM 
imaging (Figure 3), the newly synthesized NO might be initiating the Ca " elevation in 
neighboring cells and in turn causing regenerative Ca2" and NO production. To ask whether 
newly synthesized NO is required for the Ca2* wave, we incubated cells in the NOS inhibitor 
L-NMMA (300 gM, 30 min). Flash photolysis of NO in the presence of L-NMMA still 
induced a similar Ca2* wave (Figure 130), indicating that NO synthesis is not necessary for 
the propagation of the NO-initiated Ca2* wave. Consistent with this data, neither the NO 
scavenger PTIO (100 ^M, 5 min) nor the NOS inhibitor L-NMMA (300 |iM, 30 min) 
affected a mechanical stimulus-induced Ca2* wave (Figure 14). Both the percentage of 
astrocytes involved in the Ca2* wave and the average increase in Ca2* were unchanged with 
the blockade of NO signaling, suggesting that NO is not required for the propagation of the 
mechanical stimulation-induced astrocyte Ca2* wave. 
Nitric Oxide Modulates Glutamate-mediated Astrocyte-Neuron Signaling 
Previously our laboratory has shown that when an astrocyte is mechanically 
stimulated, a slow-inward current (SIC) is evoked in adjacent neurons, which results from the 
Ca2*-dependent release of glutamate from astrocytes (Araque et al., 1998a). I have asked 
whether NO modulates this SIC. 
Figure 15 shows that although the slow inward current can still be evoked when cells 
were treated with the NO scavenger PTIO and the NOS inhibitor L-NMMA, the average 
amplitude of SIC was smaller in PTIO though not L-NMMA -treated cells compared to the 
control condition (Figure 15C). These results demonstrate that while nitric oxide is neither 
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required for the Ca2* wave nor the SIC, the NO scavenger PTIO significantly reduced the 
amplitude of the SIC, suggesting that nitric oxide modulates either the glutamate release 
pathway or glutamate receptor sensitivity in neurons. However, because this is a small effect, 
it was not investigated further. 
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Figure 2. Immunocytochemistry confirmed that >99% of the cells in the purified 
astrocytes cultures are astrocytes. Cultures were labeled with antibodies against the 
astrocyte-specific protein GFAP (left image) and the neuron-specific protein MAP-2 
(right image). Both images are taken from the same area. 
Figure 3. ATP induces NO production in astrocytes. (A) An example 
fluorescence image of purified astrocytes loaded with NO sensitive dye DAF-FM. (B) 
Typical traces of 10 pM ATP-induced increase of DAF-FM fluorescence in control 
conditions (solid line) and after treatment with the NOS inhibitor L-NMMA (300 gM, 
30 minutes; dashed line). The data points are averages of all cells in the imaging field 
in one experiment. Error bars are S.E.M.s. (C) The plot of first derivative (over time) 
of ATP-induced DAF-FM fluorescence change, showing the rate of DAF-FM 
fluorescence increase. (D) Ca2* elevation by 10 gM ATP as imaged with Ca2* 
indicator fluo-3. Data in (D) is from a separate experiment than that shown in (A)-
(C), and is shown to indicate the time course of changes in cytosolic Ca2* in relation 
to NO production. 
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Figure 4. ATP-induced NO production is Ca"-dependent and P; receptor-mediated. 
(A) Summary graph showing that the nitric oxide scavenger PTIO significantly reduced 
the amplitude of ATP-induced DAF-FM fluorescence increase in astrocytes (n = 171 
cells, 4 experiments). Cells were first stimulated with 10 gM ATP for 30 seconds, then 
washed for 10 minutes in normal saline and 5 minutes in 100 gM PTIO. stimulated again 
with ATP in PTIO, then after washing in normal saline for 15 minutes, stimulated with 
ATP for a third time. (B) Pretreatment with the NOS inhibitor L-NMMA (300 |iM, 30 
minutes; n = 244 cells, 4 experiments) but not its inactive analog D-NMMA (300 |iM. 30 
minutes; n = 197 cells. 4 experiments) prevented the DAF-FM fluorescence increase 
caused by ATP (control untreated: n = 188 cells, 4 experiments). (C) Treatment with the 
Pi receptor antagonist PPADS significantly reduced the amplitude of ATP-induced DAF-
FM fluorescence increase (n = 150 cells, 4 experiments). (D) After cells were incubated 
with the Ca2* chelator BAPTA (BAPTA AM 30 gM. 45 min), ATP induced little change 
in DAF-FM fluorescence (n = 240 cells in BAPTA and 174 cells in control conditions, 4 
experiments each). Statistical differences were established using the Student's t-test at 
P< 0.05 (*), P < 0.01 (**) and P <0.001 (***). Error bars indicate S E.M.s. 
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Figure S. The NO donor SNAP induces an influx of external Ca2* into astrocytes. 
Astrocytes were loaded with fluorescent Ca2* indicator fluo-3. Cells were stimulated by 
perfusion with S-nitroso-N-acetylpenicillamine (SNAP. 100 gM), a nitric oxide donor. 
(A) A typical astrocytic Ca2* increase in response to SNAP. The trace is the average of 
all the cells in the imaging field (n = 31 cells). Error bars are S.E.M.s. The inserted 
graph shows the SNAP-induced DAF-FM fluorescence increase, confirming that SNAP 
was releasing nitric oxide. (B) Nitric oxide is responsible for the SNAP-induced Ca2* 
increase as the nitric oxide scavenger PTIO inhibited fluo-3 fluorescence increase by 
SNAP. Three application protocols were used. The first and third SNAP applications 
were used as internal controls for each cell (n = 114 cells. 3 experiments). (C) After 
washing with normal saline for 10 minutes, the same cells as shown in (A) were treated 
with zero-Ca2* saline for 30 seconds and stimulated with SNAP again. This time little 
Ca2* change was induced by SNAP. (D) The summary histogram shows that the second 
SNAP application in zero-Ca2* saline induced a smaller astrocytic Ca2* increase than the 
first (control) and third (recovery) applications in normal saline (n = 84 cells, 4 
experiments). Statistical differences were established using the Student's t-test at P< 0.05 
(*), P < 0.01 (**) and P <0.001 (***). Error bars indicate S E.M.s. 
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Figure 6. External Cd2* and 2-APB block the SNAP-induced Ca2* elevation in 
astrocytes, suggesting that NO induces a Ca2* influx through store-operated 
channels. (A) An example experiment trace showing cadmium (Cd2*, a non-specific 
Ca2* channel blocker, 100 jiM) blocked SNAP-induced Ca2* influx. The first and 
third SNAP applications were performed in normal saline, while the second SNAP 
application was performed in the presence of Cd2*. (B) Summary histogram of the 
effect of Cd2* on SNAP-induced Ca2* influx (n = 205 cells, 3 experiments). (C) 2 -
aminoethoxy-diphenyiborate (2-APB; 75 |xM, 10 min), an IP3 receptor antagonist and 
capacitive Ca2* entry inhibitor, reduced SNAP-induced Ca2* increase significantly. 
Similar protocols were used as in (A). (D) Summary histogram of the effect of 2-
APB on SNAP-induced Ca2* influx (n = 96 cells, 3 experiments). Statistical 
differences were established using the Student's t-test at P< 0.05 (*), P < 0.01 (**) 
and P <0.001 (***). Error bars indicate S E.M.s. 
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Figure 7. Treatment with PTIO during ATP application reduces astrocytic Ca2* 
responses to subsequent ATP stimulations. (A) Average traces of the intracellular 
Ca2" responses to three consecutive ATP applications, showing that after treatment 
with PTIO (100 gM) during ATP application, astrocytes responded to the subsequent 
ATP stimulation with a smaller increase in Ca2*. The first ATP application in normal 
saline was used as an internal control for each cell. For the PTIO-treated cells, PTIO 
was applied 10 minutes before the second ATP application and was then present 
throughout the reminder of the experiment. Zero-Ca2 *EGTA external saline was used 
in separate experiments to completely exclude the refilling of internal Ca2+ stores (n = 
3 experiments each, 176, 259 and 160 cells for control, PTIO-, and zero-CaEGTA-
treated group, respectively). (B) Summary of normalized Ca2* responses showing the 
significance of PTIO in reducing Ca2* signaling in response to repeated ATP 
applications. Note that in the ATP-PTIO group, the responses to the second ATP 
applications were similar as in control conditions, but the responses to the third ATP 
applications were significantly smaller, suggesting PTIO partially inhibited the 
refilling of internal Ca2* stores. Ca2* responses were normalized in each cell by 
defining the increase of fluo-3 fluorescence to the first ATP application as 100%. 
Statistical differences were established using the Student's t-test at P< 0.05 (*), P < 
0.01 (**) and P <0.001 (***). Error bars indicate S E.M.s. 
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Figure 8. Co-loading of astrocytes with two fluorescence Ca 2+ indicators, x-
rhod-1 and mag-fluo-4. (A) Simple illustration of our experimental set-up. Cells 
were first loaded with the low-affinity fluorescent Ca2* indicator mag-fluo-4 (*Q, ca= 
22 gM , Ex/Em maxima: 493/517 nm) at 37 °C for 45 minutes, then loaded with then 
high-affinity Ca2* indicator x-rhod-l(Kd.ca = 700 nM , Ex/Em maxima: 580/602 nm) 
at room temperature. Using two excitation lasers and carefully-selected emission 
filters, fluorescent signals from mag-fluo-4 and x-rhod-1 can be spectrally separated. 
(B) Two example sets of images showing astrocytes co-loaded with mag-fluo-4 and 
x-rhod-1 and viewed with 60x objective. X-rhod-l and mag-fluo-4 images are shown 
in red and green, respectively, and the third column shows the overlay of these two 
channels. X-rhod-1 staining is more homogenous, while there are clear punctate 
patterns in mag-fluo-4 staining, which are consistent with x-rhod-1 and mag-fluo-4 
loading into cytosolic and internal store compartment respectively. 
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Figure 9. X-rhod-1 and mag-fluo-4 simultaneously report Ca2* levels in cytosol 
and internal stores respectively. (A) Thapsigargin. an irreversible ER Ca2*-ATPase 
inhibitor which can increase cytosolic Ca2* by depleting ER internal Ca2" stores, led 
to a decrease of mag-fluo-4 fluorescence and an increase in x-rhod-1 fluorescence at 
the same time. The results confirm that we were simultaneously monitoring cytosolic 
and internal store (mostly ER) Ca2* with x-Rhod-l and mag-fluo-4. (B) ATP (20 (iM), 
known to induce cytosolic Ca elevation by releasing of Ca2* from ER stores, caused a 
reduction in mag-fluo-4 fluorescence and a biphasic increase of x-rhod-1 fluorescence, 
supporting that the two fluorescence signals respectively indicate cytosolic and 
internal store Ca2*. But occasionally the fluorescence signal of mag-fluo-4 may be 
mildly contaminated when cytosolic Ca2* becomes highly elevated , thus an initial 
small rise in mag-fluo-4 fluorescence in response to ATP was sometimes observed 
(left graph), which could be abolished by chelating cytosolic Ca2* with BAPTA 
(right graph, same cells as in left). (C) Experiments using zero-Ca2* EGTA external 
saline with ATP further validate the two-indicator approach for simultaneous 
monitoring of cytosolic and internal store Ca2*. In the presence of zero-Ca2* EGTA, 
the ATP-induced reduction in mag-fluo-4 fluorescence could not recover after the 
removal of ATP until Ca2* was reintroduced into the bath, and the increase in x-rhod-
l fluorescence lacked an elevated plateau phase, both consistent with effects of an 
elimination of Ca2* influx. 
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Figure 10. ATP induces release of Ca2* from internal stores and subsequent 
store refilling. (A) An example experiment showing that the ATP-evoked increase 
in cytosolic Ca2* results from the release of Ca2* from internal stores. These images 
are peudocolor images of mag-fluo-4 and x-rhod-l fluorescence corresponding to 
times labeled in the graph in (B) (a: before ATP application: b: 10 sec after starting 
ATP: c: 40 sec after starting ATP: d: 2 minutes after removal of ATP showing full 
recovery). Note that mag-fluo-4 fluorescence decreased and x-rhod-l fluorescence 
increased in response to ATP, but 2 minutes after the removal of ATP, both signals 
went back to their base levels. (B) Traces showing the average changes in mag-fluo-
4 and x-rhod-1 fluorescence of the cells in (A). 
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Figure II. The NO scavenger PTIO reduced the refilling of internal Ca2> stores. 
(A) Example traces of one experiment, showing the ATP-induced elevation of 
cytosolic Ca2"" and depletion of internal store Ca2*" and subsequent store refilling in 
PTIO-treated cells. Note that unlike control conditions (figure 9), internal Ca2* store 
only partially refilled in the presence of PTIO. The horizontal lines in the graph are 
artificial lines drawn to indicate the baseline level (b: average of 3 frames 
immediately before ATP application), maxima decrease (v) and recovered level (r; 
average of 3 frames before 2 minutes post-ATP removal) of mag-fluo-4 dF/FO. J/ 
and J2 are the differences of (b and v) and (r and v), respectively. (B) Summary of 
the effect of PTIO on internal Ca2* store refilling. The refilling percentage is 
defined as J2 / J/ * 100%. In PTIO-treated cells, the refilling percentage was 
significantly reduced (n = 9 experiments each). Statistical differences were 
established using the Student's t-test at P< 0.05 (*), P < 0.01 (**) and P <0.001 
(***). (C) The time-course of the changes in internal store Ca2+ level in control 
conditions and in PTIO-treated cells, demonstrating that internal stores did not fully 
refill in the presence of PTIO compared to the control conditions. The data points 
represent the average of all the cells in all experiments for each group. The 
normalized store depletion percentage is calculated in each cell based on 0% 
depletion at rest before ATP application and -100% as maximum depletion after 
each ATP application. Error bars indicate S.E.M.s. 
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Figure 12. Photo-release of nitric oxide induces a Ca:+ elevation in the 
stimulated astrocyte. (A) Our photolysis set-up provides a fast and localized NO 
source. It consists of a 337 nm photolysis UV laser coupled with an optical fiber 
together with a 635 nm positioning laser. The photolysis spot is approximally 6 gm 
in diameter. Changes in Ca2> level were monitored in purified astrocyte cultures with 
fluo-3. Caged NO (1 mM) was introduced into the bath. (B) An example of the Ca2+ 
elevation in an astrocyte directly stimulated with NO photo-released by 1 UV pulse (3 
ns). The arrow indicates the time of photolysis. (C) The summary graph showing 
that photo-liberation of NO caused an increase in Ca2+ (column 1, n = 6) which is 
prevented by the NO scavenger PTIO (column 3, n = 3). UV illumination without the 
presence of caged compound did not induce a change in fluo-3 fluorescence (column 
2, n = 4). Statistical differences were established using the Student's t-test at P< 0.05 
(*), P < 0.01 (**) and P <0.001 (***). Error bars indicate S.E.M.s. 
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Figure 13. Photo-release of NO initiates an intercellular Ca2* wave between 
astrocytes. 
(A) A representative example of NO-induced Ca2+ waves. The images are sequential 
peudocolor images from immediately before photolysis to 12 seconds after stimulation. 
The arrow and white circle inside the second image indicates the timing and position of 
photolysis. Fluo-3 fluorescence first increased in the stimulated astrocyte, and 
subsequently propagated to the neighbors. (B) Lateral diffusion of nitric oxide does not 
cause the Ca2+ wave. When the photolysis site (represented by the white circle) was 
adjacent to but not on the cell (Bl), lateral diffusion of photo-released nitric oxide did not 
cause a Ca2+ elevation in this astrocyte. In (B2), the same astrocyte in (Bl) was then 
moved into the photolysis spot, and photo-release of nitric oxide induced a Ca2+ elevation 
in the flashed astrocyte and subsequently in neighbors. (C) New nitric oxide synthesis is 
not required for the Ca2+ wave initiated by photo-released nitric oxide. Astrocytes were 
incubated with the nitric oxide synthases inhibitor L-NMMA (300|iM) for 30 minutes 
before Ca2-r imaging. Photo-release of nitric oxide still induced a similar astrocytic Ca2+ 
wave. 

Figure 14. Incubation in NOS inhibitor or NO scavenger does not prevent 
mechanical-stimulation-induced Ca2+ signaling. (A) An example of mechanical 
stimulation-induced Ca2+ wave. Purified astrocyte cultures were loaded with Ca2"" 
indicator Fluo-3. Mechanical stimulations were performed by gently touch an astrocyte 
with a glass micropipette filled with external saline. The leftmost is the bright-field 
image. We can clearly see the micropipette tip position. The right images are sequential 
images from immediately before mechanical stimulation to 12 seconds after stimulation. 
The arrow inside the second image indicates the time when the mechanical stimulus was 
applied. Fluo-3 fluorescence first increased in the touched cell, and then in the 
neighboring cells. (B) PTIO (nitric oxide scavenger, 100 p.M. 5 min) and L-NMMA 
(nitric oxide synthases inhibitor, 300 |iM, 30 min) did not reduce mechanical stimulation-
induced astrocyte Ca2> wave. Neither the percentage of cells exhibiting a Ca2+ increase 
nor the amplitude of average in crease in fluorescence intensity was affected by PTIO (n 
= 25 experiments) or L-NMMA (n = 8) treatment (Control, n = 21). Bars represent 
S.E.M.s. Statistical differences were established using the Student's t-test at P< 0.05. 
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Figure 15. Nitric oxide is not required for the astrocyte-evoked glutamate-
dependent slow inward current. (A) Schematic diagram representing a confluent layer 
of astrocytes (thin lines) and two neurons (thick lines). Astrocytes were mechanically 
stimulated with a glass micropipette, and whole cell currents were recorded from adjacent 
neurons. (B) A typical slow inward current (SIC) evoked by astrocyte stimulation. The 
asterisk indicates the timing of the stimulus. (C) Summary of the effects of the NO 
scavenger PTIO and the NOS inhibitor L-NMMA on SIC incidence and amplitude. SICs 
could still be evoked after the treatment of PTIO (100 |iM) or L-NMMA (300 gM), but 
were evoked in fewer cells (n = 10, 5 and 4 experiments for control, PTIO and L-NMMA, 
respectively), with a smaller amplitude (n = 67, 33 and 32 responded neurons for control, 
PTIO and L-NMMA, respectively). The NMDA receptor antagonist D-AP5 (50 |iM) and 
the non-NMDA receptor antagonist CNQX (20 gM) were used to confirm the glutamate-
dependency of SICs (n = 3 experiments, 5 responded cells). Only currents > 10 pA were 
considered to be astrocyte-evoked SIC, i.e. at least three times higher than the standard 
deviation of the baseline noise. Statistical differences were established using the 
Student's t-test at P< 0.05 (*), P < 0.01 (**) and P <0.001 (***). Error bars represents 
S.E.M.S. 
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CHAPTER 5. DISCUSSION AND CONCLUSION 
Ca2*-dependent Nitric Oxide Production 
Using the NO-sensitive fluorescent indicator DAF-FM, I observed that ATP, an 
important messenger in astrocytic Ca2+ waves, induced a cellular production of NO in 
purified astrocyte cultures. This NO production is Ca2+-dependent and P% receptor-mediated, 
since the Ca2+-chelator BAPTA and the Pi receptor antagonist PPADS both blocked the 
ATP-induced NO production. To my knowledge, this is the first report directly visualizing 
NO production in astrocytes induced by a natural cellular messenger such as ATP. The ATP 
concentration we used is in the physiological range (10 gM), which implies that this NO 
production can happen under physiological conditions. The ATP-induced generation of NO 
was also blocked by a broad-spectrum NOS inhibitor L-NMMA, in agreement with the 
function of NOSs in forming NO. Although I couldn't differentiate the specific isoforms of 
NOSs with my pharmacological studies, it is likely that the Ca2*-dependent constitutive 
NOSs (eNOSs and nNOSs) are responsible, based on the Ca2+-dependence of this ATP-
induced NO production. NO has profound roles in the central nervous system, and is 
considered as a "double-edged sword", referring to its neuromodulating and neuroprotective 
roles at low concentrations and neurotoxic roles at high concentrations which usually occur 
due to the activation of iNOSs during pathological conditions. Although DAF-FM does not 
quantitatively measure NO levels, it is reasonable to speculate that this astrocytic Ca2+-
dependent NO synthesis would be in the range of normal physiological concentrations, and 
therefore might be involved in modulating normal information processing. 
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Nitric Oxide Induces Car* influx into Astrocytes and Modulates Internal CaStore 
Refilling 
When a NO donor, SNAP, was applied to purified astrocyte cultures, it induced a 
NO-dependent Ca2"- increase in astrocytes. This increase in Ca2* was due to an influx of Ca2* 
from the extracellular space, since both zero-Ca2* external saline and the non-specific Ca2* 
channel blocker Cd2* both abolished this Ca2* increase. In agreement with my finding is the 
recent report by Matyash et al., in which the authors reported that NO-triggered Ca2> influx 
into Bergmann glial cells (Matyash et al., 2001). 8-Br-cGMP, an agonistic analog of cGMP, 
did not induce a detectable Ca2* change, suggesting that the NO-induced Ca2* increase is via 
a cGMP-independent pathway. Willmott et al. reported that NO induced Ca2* mobilization 
via cGMP-G Kinase-dependent activation of ryanodine receptors (Willmott et al., 2000). 
However, because they used mixed cultures of astrocytes and neurons, they were unable to 
confirm that the NO effect that they observed in astrocytes was due to NO stimulation of 
astrocytes rather than to NO stimulation of adjacent neurons. The result that the cGMP 
pathway is not involved in the NO-induced Ca2* influx in astrocytes is not surprising, since 
this pathway is now known to be only one of the numerous NO targets. Recently it was also 
reported that NO can induce a cGMP-independent Ca2* influx in endothelial cells (Berkels et 
al., 2000). Further experiments will be needed to dissect out the components involved in the 
NO-induced Ca2* influx in astrocytes. 
The NO-induced Ca2* influx in astrocytes can be blocked by 2-APB, an antagonist of 
the IP] receptor and the capacitative Ca2* entry pathway, suggesting that this NO-induced 
Ca2* influx is possibly through store-operated Ca2* channels. S-nitrosylation is emerging as 
an important specific post-translational modification of numerous proteins. Store-operated 
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Ca2* channels are known targets of S-nitrosylation (Favre et al., 1998; Ma et al., 1999; van 
Rossum et al., 2000). NO could directly modulate store operated channels and thus induce 
an influx of Ca2*. Store-operated channels and the CCE pathway have not been well 
characterized in astrocytes. It will be interesting to test whether Lnc can be recorded from 
astrocytes, and whether NO can modulate this current. 
To further understand the consequences of NO-induced Ca2* influx in astrocytes, I 
determined if NO could modulate the refilling of internal Ca2* stores. Results from the three 
ATP application experiments provide indirect evidence that NO might modulate the refilling 
of internal Ca2* stores. Treatment with the NO scavenger, PTIO, during ATP application 
reduced the magnitude of the Ca2* response to a subsequent ATP application, suggesting that 
internal Ca2* stores are unable to fully replenish when NO signaling is blocked. 
In order to more directly address this question, I directly imaged changes in internal store 
Ca2*, and simultaneously monitored the changes in cytosolic Ca2*. By loading the same 
astrocytes with two fluorescent Ca2* indicators with different spectral profiles and with 
different Ca2*-affinities, I managed to separate the internal store Ca2* signal from the 
cytosolic Ca2* signal. The separation of the two signals was first supported by the 
observation of the different fluorescent patterns generated by the two dyes in a single cell. X-
rhod-1 staining is more homogenous, while mag-fluo-4 staining shows clear punctate 
patterns in the periphery of cells and devoid of fluorescence in nuclear regions (reflecting the 
cytoplasmic), which is consistent with x-rhod-1 and mag-fluo-4 loading into cytosol and 
internal stores respectively. Then the series of experiments using the Ca2*-ATPase inhibitor 
thapsigargin and the Ca2* mobilizing messenger ATP confirmed that these two fluorescence 
indicators report Ca2* changes in the two different compartments. Thapsigargin reduced 
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mag-fluo-4 fluorescence and simultaneously increased x-rhod-l fluorescence, consistent with 
thapsigargin induced Ca"* leak from internal stores; ATP induced a biphasic increase of x-
rhod-1 fluorescence and a simultaneous reduction of the fluorescence of mag-fluo-4, in 
agreement with ATP-induced Ca2* release from internal stores; and mag-fluo-4 fluorescence 
could not return to the base level in the presence of zero-Ca2*EGTA, consistent with zero-
Ca2*EGTA preventing Ca2* influx and store refilling. Taken together, these results supported 
the notion that x-rhod-l and mag-fluo-4 report changes in cytosolic and internal Ca2* 
respectively. 
However, occasionally mag-fluo-4 fluorescence can be contaminated with highly 
elevated cytosolic Ca2*, as a small transient rise in mag-fluo-4 fluorescence signal was 
sometimes observed in response to ATP, which was abolished after chelating cytosolic Ca2* 
with BAPTA. Since my main interest is in the magnitude of store depletion and refilling at a 
time when cytosolic Ca2* is already lowered from it peak, these two fluorescence signals 
were appropriate indicators for cytosolic and internal store Ca2*. An additional consideration 
is that mag-fluo-4 also becomes fluorescent upon Mg2* binding (Kd. .vig = 4.7 mM). In 
internal stores the free Ca2* concentration is estimated to be -110-150 pM in astrocytes 
(Golovina and Blaustein, 1997, 2000), about 5-7 times of Kd.ca. and the Mg2* concentration is 
estimated to be -1 mM, only 1/5 of FQ. Mg (Sugiyama and Goldman, 1995), thus mag-fluo-4 
preferentially bind to Ca2* in internal stores. 
The role of NO in refilling of internal stores was then examined by pre-treating 
astrocytes with the NO scavenger PTIO and then applying ATP. ATP induced Ca2* release 
from internal stores and internal stores were refilled after the removal of ATP. After 
blocking NO signaling, the refilling percentage of internal stores following ATP stimulation 
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was significantly reduced to about 70%, compared to a little over 100% refilling in control 
conditions. 
Many neurotransmitters such as glutamate and ATP cause an IPs-receptor-mediated 
Ca2* release from ER Ca2* stores in astrocytes (Cornell-Bell et al., 1990; Charles et al.. 1993; 
Salter and Hicks, 1995; Venance et al., 1997). However, little is known about the 
mechanism of store refilling in astrocytes. Although the capacitative Ca2* entry (CCE) 
pathway has been suggested in this store-depletion-induced store refilling, the existence and 
characteristics of CCE pathway in astrocytes has not been well investigated. Collectively our 
findings suggest that the Ca2*-dependent NO production has a role in modulating the refilling 
of internal Ca2* stores in astrocytes, which is a very important link in the chain of Ca2* 
signaling events. 
There appears also to be NO-independent components in Ca2* store refilling, since 
PTIO only blocked about 30% of store refilling. This might result from existence of both 
NO-dependent and NO-independent pathways in the store refilling process. Alternatively, the 
NO modulation effect could be fine-tuned in which case NO levels would be tightly linked to 
the ratio of Ca2* entry and release. The store refilling is a very complicated process. In 
addition to capacitative Ca2* entry, it may also involve Ca2* recycling from cytosoi and Ca2* 
shuffling from other organelles like mitochondria. We found that NO can modulate the 
refilling of internal stores, but the exact mechanism of NO regulation will need further 
examination. 
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Nitric Oxide Initiates but Does Not Propagate the Ca2* Wave between Astrocytes 
Taking advantage of our photolysis set-up, we directly photo-released NO onto a 
single astrocyte, and found that NO not only induced a Ca2* elevation in the directly 
stimulated astrocyte, but also initiated an intercellular propagating Ca2* wave in neighboring 
astrocytes, that was similar in time course and magnitude to the previously characterized 
mechanical stimulation-induced Ca2* wave. We performed careful control experiments and 
confirmed that these Ca2* responses were only due to photo-released NO directly on the 
stimulated astrocytes but not due to photodamage or diffusion of photoliberated NO. This 
finding adds NO to the list of neurotransmitters which can induce glial Ca2* waves, and thus 
reveal a new pathway for initiation of a Ca2* wave. 
The propagation of Ca2* waves does not require NO, since neither the NO-induced 
Ca2* wave nor the mechanical stimulation-induced Ca2* wave was affected by the inhibition 
of NOSs. This finding is in agreement with our current knowledge about the Ca2* wave 
mechanisms (Guthrie et al., 1999: Haydon, 2001). Although NO can be generated from the 
directly stimulated astrocytes, the concentration of newly-synthesized NO is probably not 
sufficient to mediate a regenerative wave of Ca2* rise in neighboring cells. Other messengers 
should be responsible for propagating of the NO-induced Ca2* waves. ATP and possibly 
glutamate are good candidates. Additional experiments using antagonists of ATP or 
glutamate signaling pathway could confirm this speculation. Another interesting experiment 
would be to image the ATP production (if any) in astrocytes during NO-induced Ca2* waves. 
The pathway for ATP release in astrocytes is not understood. It is only known that the ATP 
release is not Ca2*-dependent (Wang et al., 2000), possibly PLC-dependent (Guthrie et al., 
1999), and unlikely to be SNARE-dependent (Araque et al., 2000). Since ATP can cause 
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Ca2*-dependent NO production in astrocytes, how NO induces the release of ATP would be a 
very interesting question concerning the complicated web of Ca2* signaling in astrocytes. 
Nitric Oxide in Glutamate-mediated Astrocyte-Neuron Signaling 
A Ca2* elevation in an astrocyte is necessary and sufficient to induce the release of 
glutamate (Parpura et al.. 1994; Araque et al., 1998a). Glutamate from astrocytes is able to 
modulate neuronal activity and neurotransmission (Araque et al., 1998a; Araque et al., 1998b; 
Kang et al., 1998; Newman and Zahs, 1998; Parpura and Haydon, 2000). The astrocyte-
evoked neuronal slow inward current is an example of this modulation. We found that NO is 
not required for the induction of slow-inward current, but PTIO reduced the magnitude of 
SIC, suggesting that NO has modulatory roles in this glutamate-dependent event. The effect 
of NO may result from a combination of its roles in different steps of SIC generation. 
Because NO can modulate Ca2* signaling in astrocytes, we would expect NO might modulate 
Ca2*-dependent glutamate release from astrocytes. Because astrocytic release of glutamate is 
also known to be SNARE protein-dependent (Araque et al., 2000; Pasti et al., 2001), NO 
might directly modulate the release machinery by S-nitrosylation of specific SNARE proteins. 
NO can also directly S-nitrosylate NMDA receptors of neurons and thus may modulate the 
glutamate-sensitivity of receptors. 
We selected the SIC as a model to investigate the roles of NO in astrocyte-neuron 
signaling, but it is worth noting that the effect of NO in astrocyte-neuron signaling need not 
be limited to glutamate-mediated signaling. The astrocyte-originated NO could directly act 
on neurons and modulate numerous processes in synaptic transmission. 
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Concluding Remarks 
In this dissertation, I demonstrated the Ca2*-dependent production of nitric oxide in 
astrocytes, explored the roles of NO in astrocyte Ca2* signaling and astrocyte-neuron 
interaction. A schematic model of the generation and effects of NO in astrocytes is presented 
in Figure 15, which shows that ATP induces Ca2* release from IP3 receptor-mediated internal 
stores, and thus induces a Ca2*-dependent production of NO. NO can then modulate the 
refilling of internal Ca2* stores by inducing an influx of Ca2* through store-operated Ca2* 
channels, and also modulate the Ca2*-dependent release of glutamate from astrocytes. In 
addition. NO diffuses through cell membranes, and thereby can directly act on other 
neighboring cells. 
In vitro culture systems were used in this study because of their simplicity and more 
importantly because they allow us to selectively investigate the astrocytic generation of NO 
and responses to NO. This NO signaling is unlikely the artifact of culture system. Because 
astrocytic Ca2* signaling and Ca2*-dependent release of glutamate has been demonstrated in 
situ, and physiological concentrations of ATP can induce the production of NO, thus Ca2*-
dependent NO production and NO signaling is highly likely present in intact nervous systems. 
But future studies should be expanded to in situ and in vivo system so that we will understand 
more about astrocyte NO signaling in more physiological conditions. 
During the progress of this research, I became more and more fascinated about the 
diverse roles of this gaseous messenger, NO. In the CNS, astrocytes make contacts with both 
neuronal membranes and blood vessels. Astrocytes could receive NO from adjacent 
neuronal synapses, neighboring astrocytes or adjacent endothelial cells. NO from all origins 
can modulate Ca2* signaling in astrocytes and in turn modulate release of glutamate from 
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astrocytes and glutamate-mediated astrocyte-neuron signaling. Additionally, astrocytes can 
generate NO following a Ca2+ increase induced by various neurotransmitters (including 
glutamate, ATP and NO). This astrocyte-derived NO can also signal to neurons and 
modulate synaptic plasticity, or signal to endothelial cells of blood vessels and thereby 
controlling the relationship (normal or pathological) between neural activity and blood 
flow/energy supply in the CNS. 
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Figure 16. A schematic diagram showing a model of the generation and functions of 
NO in astrocytes. ATP induces Ca2* release from IP3 receptor-mediated internal stores, and 
thus induces a Ca2+-dependent production of NO. NO can then modulate the refilling of 
internal Ca2* stores by inducing an influx of Ca2* through store-operated Ca2* channels, and 
also modulate the Ca2+-dependent release of glutamate from astrocytes. In addition, NO 
diffuses through cell membranes, and thereby can directly act on other neighboring cells. 
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